(R)-Verapamil (hydrochloride)

Clear Filter

Results for "(R)-Verapamil (hydrochloride)_SNU-1": 1001 gene sets

Name
(R)-Verapamil (hydrochloride)_SNU-1 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the (R)-Verapamil (hydrochloride)_SNU-1 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Lidocaine (hydrochloride)_SNU-423 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Lidocaine (hydrochloride)_SNU-423 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Ivabradine (hydrochloride)_SNU-423 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Ivabradine (hydrochloride)_SNU-423 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Esmolol (hydrochloride)_SNU-423 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Esmolol (hydrochloride)_SNU-423 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Doxorubicin (hydrochloride)_SNU-423 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Doxorubicin (hydrochloride)_SNU-423 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Pyridoxine (hydrochloride)_SNU-423 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Pyridoxine (hydrochloride)_SNU-423 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Cysteamine (hydrochloride)_SNU-423 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Cysteamine (hydrochloride)_SNU-423 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
(R)-Verapamil (hydrochloride)_SNU-423 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the (R)-Verapamil (hydrochloride)_SNU-423 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Dorzolamide (hydrochloride)_SNU-423 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Dorzolamide (hydrochloride)_SNU-423 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Ropivacaine (hydrochloride monohydrate)_SNU-423 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Ropivacaine (hydrochloride monohydrate)_SNU-423 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Pexidartinib (hydrochloride)_SNU-423 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Pexidartinib (hydrochloride)_SNU-423 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Topotecan (hydrochloride)_SNU-423 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Topotecan (hydrochloride)_SNU-423 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Doxorubicin (hydrochloride)_SNU-1 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Doxorubicin (hydrochloride)_SNU-1 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Phenylephrine (hydrochloride)_SNU-1 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Phenylephrine (hydrochloride)_SNU-1 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Fingolimod (hydrochloride)_SNU-423 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Fingolimod (hydrochloride)_SNU-423 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Procainamide (hydrochloride)_SNU-1 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Procainamide (hydrochloride)_SNU-1 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Clonidine (hydrochloride)_SNU-1 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Clonidine (hydrochloride)_SNU-1 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Tetracycline (hydrochloride)_SNU-423 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Tetracycline (hydrochloride)_SNU-423 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Norepinephrine (hydrochloride)_SNU-423 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Norepinephrine (hydrochloride)_SNU-423 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Irinotecan (hydrochloride)_SNU-423 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Irinotecan (hydrochloride)_SNU-423 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Fingolimod (hydrochloride)_SNU-1 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Fingolimod (hydrochloride)_SNU-1 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Epirubicin (hydrochloride)_SNU-423 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Epirubicin (hydrochloride)_SNU-423 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Cytarabine (hydrochloride)_SNU-423 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Cytarabine (hydrochloride)_SNU-423 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Phenylephrine (hydrochloride)_SNU-423 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Phenylephrine (hydrochloride)_SNU-423 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Methyl aminolevulinate (hydrochloride)_SNU-423 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Methyl aminolevulinate (hydrochloride)_SNU-423 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Fedratinib (hydrochloride hydrate)_SNU-423 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Fedratinib (hydrochloride hydrate)_SNU-423 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Topotecan (hydrochloride)_SNU-1 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Topotecan (hydrochloride)_SNU-1 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Ivabradine (hydrochloride)_SNU-1 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Ivabradine (hydrochloride)_SNU-1 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Fedratinib (hydrochloride hydrate)_SNU-1 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Fedratinib (hydrochloride hydrate)_SNU-1 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Cysteamine (hydrochloride)_SNU-1 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Cysteamine (hydrochloride)_SNU-1 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Cytarabine (hydrochloride)_SNU-1 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Cytarabine (hydrochloride)_SNU-1 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Rimonabant (Hydrochloride)_SNU-423 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Rimonabant (Hydrochloride)_SNU-423 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Bestatin (hydrochloride)_SNU-1 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Bestatin (hydrochloride)_SNU-1 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Loperamide (hydrochloride)_SNU-1 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Loperamide (hydrochloride)_SNU-1 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Lidocaine (hydrochloride)_SNU-1 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Lidocaine (hydrochloride)_SNU-1 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Esmolol (hydrochloride)_SNU-1 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Esmolol (hydrochloride)_SNU-1 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Tetracycline (hydrochloride)_SNU-1 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Tetracycline (hydrochloride)_SNU-1 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Ropivacaine (hydrochloride monohydrate)_SNU-1 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Ropivacaine (hydrochloride monohydrate)_SNU-1 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Pexidartinib (hydrochloride)_SNU-1 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Pexidartinib (hydrochloride)_SNU-1 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Methyl aminolevulinate (hydrochloride)_SNU-1 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Methyl aminolevulinate (hydrochloride)_SNU-1 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Epirubicin (hydrochloride)_SNU-1 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Epirubicin (hydrochloride)_SNU-1 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Tirabrutinib (hydrochloride)_SNU-1 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Tirabrutinib (hydrochloride)_SNU-1 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Almonertinib (hydrochloride)_SNU-1 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Almonertinib (hydrochloride)_SNU-1 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Levobupivacaine (hydrochloride)_SNU-1 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Levobupivacaine (hydrochloride)_SNU-1 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Rimonabant (Hydrochloride)_SNU-1 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Rimonabant (Hydrochloride)_SNU-1 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Procainamide (hydrochloride)_SNU-423 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Procainamide (hydrochloride)_SNU-423 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Imiquimod (hydrochloride)_SNU-1 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Imiquimod (hydrochloride)_SNU-1 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Idarubicin (hydrochloride)_SNU-1 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Idarubicin (hydrochloride)_SNU-1 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Crizotinib (hydrochloride)_SNU-423 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Crizotinib (hydrochloride)_SNU-423 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Loperamide (hydrochloride)_SNU-423 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Loperamide (hydrochloride)_SNU-423 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Clonidine (hydrochloride)_SNU-423 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Clonidine (hydrochloride)_SNU-423 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Tirabrutinib (hydrochloride)_SNU-423 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Tirabrutinib (hydrochloride)_SNU-423 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Idarubicin (hydrochloride)_SNU-423 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Idarubicin (hydrochloride)_SNU-423 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Bestatin (hydrochloride)_SNU-423 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Bestatin (hydrochloride)_SNU-423 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Dorzolamide (hydrochloride)_SNU-1 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Dorzolamide (hydrochloride)_SNU-1 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Pyridoxine (hydrochloride)_SNU-1 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Pyridoxine (hydrochloride)_SNU-1 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Norepinephrine (hydrochloride)_SNU-1 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Norepinephrine (hydrochloride)_SNU-1 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Imiquimod (hydrochloride)_SNU-423 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Imiquimod (hydrochloride)_SNU-423 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Crizotinib (hydrochloride)_SNU-1 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Crizotinib (hydrochloride)_SNU-1 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Irinotecan (hydrochloride)_SNU-1 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Irinotecan (hydrochloride)_SNU-1 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Levobupivacaine (hydrochloride)_SNU-423 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Levobupivacaine (hydrochloride)_SNU-423 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Almonertinib (hydrochloride)_SNU-423 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Almonertinib (hydrochloride)_SNU-423 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Lactate (calcium)_SNU-423 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Lactate (calcium)_SNU-423 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Lumateperone (tosylate)_SNU-1 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Lumateperone (tosylate)_SNU-1 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Fluvoxamine (maleate)_SNU-1 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Fluvoxamine (maleate)_SNU-1 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Balsalazide (sodium hydrate)_SNU-423 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Balsalazide (sodium hydrate)_SNU-423 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Carbidopa (monohydrate)_SNU-423 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Carbidopa (monohydrate)_SNU-423 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Dapagliflozin ((2S)-1,2-propanediol, hydrate)_SNU-423 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Dapagliflozin ((2S)-1,2-propanediol, hydrate)_SNU-423 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Selinexor _SNU-423 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Selinexor _SNU-423 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Citalopram (hydrobromide)_SNU-423 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Citalopram (hydrobromide)_SNU-423 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Pitavastatin (Calcium)_SNU-423 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Pitavastatin (Calcium)_SNU-423 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Neratinib (maleate)_SNU-423 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Neratinib (maleate)_SNU-423 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Fluvoxamine (maleate)_SNU-423 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Fluvoxamine (maleate)_SNU-423 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Omeprazole (sodium)_SNU-423 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Omeprazole (sodium)_SNU-423 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
L-Thyroxine (sodium salt pentahydrate)_SNU-423 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the L-Thyroxine (sodium salt pentahydrate)_SNU-423 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Flumatinib (mesylate)_SNU-423 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Flumatinib (mesylate)_SNU-423 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Perindopril (erbumine)_SNU-423 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Perindopril (erbumine)_SNU-423 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Doxycycline (monohydrate)_SNU-423 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Doxycycline (monohydrate)_SNU-423 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Almonertinib (mesylate)_SNU-423 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Almonertinib (mesylate)_SNU-423 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Selinexor _SNU-1 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Selinexor _SNU-1 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Azithromycin (hydrate)_SNU-423 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Azithromycin (hydrate)_SNU-423 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Indacaterol (maleate)_SNU-423 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Indacaterol (maleate)_SNU-423 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Benproperine (phosphate)_SNU-1 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Benproperine (phosphate)_SNU-1 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Cloxacillin (sodium)_SNU-1 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Cloxacillin (sodium)_SNU-1 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Pitavastatin (Calcium)_SNU-1 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Pitavastatin (Calcium)_SNU-1 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Bosentan (hydrate)_SNU-423 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Bosentan (hydrate)_SNU-423 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Canagliflozin (hemihydrate)_SNU-423 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Canagliflozin (hemihydrate)_SNU-423 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
S-Adenosyl-L-methionine (disulfate tosylate)_SNU-423 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the S-Adenosyl-L-methionine (disulfate tosylate)_SNU-423 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Palmatine (chloride)_SNU-423 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Palmatine (chloride)_SNU-423 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Pentamidine (isethionate)_SNU-423 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Pentamidine (isethionate)_SNU-423 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Mitoxantrone (dihydrochloride)_SNU-423 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Mitoxantrone (dihydrochloride)_SNU-423 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Lumateperone (tosylate)_SNU-423 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Lumateperone (tosylate)_SNU-423 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Vinblastine (sulfate)_SNU-423 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Vinblastine (sulfate)_SNU-423 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Lenalidomide (hemihydrate)_SNU-423 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Lenalidomide (hemihydrate)_SNU-423 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Ouabain (Octahydrate)_SNU-423 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Ouabain (Octahydrate)_SNU-423 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Erdafitinib _SNU-423 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Erdafitinib _SNU-423 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Docetaxel (Trihydrate)_SNU-423 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Docetaxel (Trihydrate)_SNU-423 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Quinidine (15% dihydroquinidine)_SNU-423 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Quinidine (15% dihydroquinidine)_SNU-423 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Rucaparib (phosphate)_SNU-423 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Rucaparib (phosphate)_SNU-423 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Chlorhexidine (diacetate)_SNU-423 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Chlorhexidine (diacetate)_SNU-423 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Tofacitinib (citrate)_SNU-423 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Tofacitinib (citrate)_SNU-423 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Canagliflozin (hemihydrate)_SNU-1 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Canagliflozin (hemihydrate)_SNU-1 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Cabozantinib (S-malate)_SNU-423 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Cabozantinib (S-malate)_SNU-423 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Imiquimod (maleate)_SNU-423 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Imiquimod (maleate)_SNU-423 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Atazanavir (sulfate)_SNU-1 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Atazanavir (sulfate)_SNU-1 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Berbamine (dihydrochloride)_SNU-1 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Berbamine (dihydrochloride)_SNU-1 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Lactate (calcium)_SNU-1 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Lactate (calcium)_SNU-1 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Cabozantinib (S-malate)_SNU-1 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Cabozantinib (S-malate)_SNU-1 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
L-Eflornithine (monohydrochloride)_SNU-1 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the L-Eflornithine (monohydrochloride)_SNU-1 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Phenytoin (sodium)_SNU-1 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Phenytoin (sodium)_SNU-1 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
L-Thyroxine (sodium salt pentahydrate)_SNU-1 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the L-Thyroxine (sodium salt pentahydrate)_SNU-1 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Bisoprolol (hemifumarate)_SNU-423 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Bisoprolol (hemifumarate)_SNU-423 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Sivelestat (sodium tetrahydrate)_SNU-423 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Sivelestat (sodium tetrahydrate)_SNU-423 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Rutin (trihydrate)_SNU-423 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Rutin (trihydrate)_SNU-423 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Bisoprolol (hemifumarate)_SNU-1 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Bisoprolol (hemifumarate)_SNU-1 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Bosentan (hydrate)_SNU-1 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Bosentan (hydrate)_SNU-1 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Azithromycin (hydrate)_SNU-1 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Azithromycin (hydrate)_SNU-1 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Dapagliflozin ((2S)-1,2-propanediol, hydrate)_SNU-1 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Dapagliflozin ((2S)-1,2-propanediol, hydrate)_SNU-1 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Indacaterol (maleate)_SNU-1 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Indacaterol (maleate)_SNU-1 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Mitoxantrone (dihydrochloride)_SNU-1 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Mitoxantrone (dihydrochloride)_SNU-1 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Citalopram (hydrobromide)_SNU-1 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Citalopram (hydrobromide)_SNU-1 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Lenalidomide (hemihydrate)_SNU-1 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Lenalidomide (hemihydrate)_SNU-1 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Goserelin (acetate)_SNU-1 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Goserelin (acetate)_SNU-1 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Chlorhexidine (diacetate)_SNU-1 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Chlorhexidine (diacetate)_SNU-1 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Tofacitinib (citrate)_SNU-1 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Tofacitinib (citrate)_SNU-1 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Fostamatinib (disodium hexahydrate)_SNU-1 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Fostamatinib (disodium hexahydrate)_SNU-1 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Estrone sulfate (potassium)_SNU-1 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Estrone sulfate (potassium)_SNU-1 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Sivelestat (sodium tetrahydrate)_SNU-1 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Sivelestat (sodium tetrahydrate)_SNU-1 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Gallic acid (hydrate)_SNU-1 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Gallic acid (hydrate)_SNU-1 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Balsalazide (sodium hydrate)_SNU-1 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Balsalazide (sodium hydrate)_SNU-1 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Benztropine (mesylate)_SNU-1 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Benztropine (mesylate)_SNU-1 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Erdafitinib _SNU-1 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Erdafitinib _SNU-1 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Carbidopa (monohydrate)_SNU-1 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Carbidopa (monohydrate)_SNU-1 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Pentamidine (isethionate)_SNU-1 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Pentamidine (isethionate)_SNU-1 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Rutin (trihydrate)_SNU-1 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Rutin (trihydrate)_SNU-1 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Perindopril (erbumine)_SNU-1 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Perindopril (erbumine)_SNU-1 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Pravastatin (sodium)_SNU-1 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Pravastatin (sodium)_SNU-1 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Edoxaban (tosylate monohydrate)_SNU-1 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Edoxaban (tosylate monohydrate)_SNU-1 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Doxycycline (monohydrate)_SNU-1 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Doxycycline (monohydrate)_SNU-1 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Omeprazole (sodium)_SNU-1 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Omeprazole (sodium)_SNU-1 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
LY-2584702 (tosylate salt)_SNU-1 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the LY-2584702 (tosylate salt)_SNU-1 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Entecavir (monohydrate)_SNU-1 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Entecavir (monohydrate)_SNU-1 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Berberine (chloride hydrate)_SNU-1 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Berberine (chloride hydrate)_SNU-1 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Osimertinib (mesylate)_SNU-1 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Osimertinib (mesylate)_SNU-1 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Vinblastine (sulfate)_SNU-1 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Vinblastine (sulfate)_SNU-1 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Neratinib (maleate)_SNU-1 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Neratinib (maleate)_SNU-1 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Nafamostat (mesylate)_SNU-1 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Nafamostat (mesylate)_SNU-1 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Belumosudil (mesylate)_SNU-1 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Belumosudil (mesylate)_SNU-1 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Flumatinib (mesylate)_SNU-1 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Flumatinib (mesylate)_SNU-1 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Niclosamide (olamine)_SNU-423 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Niclosamide (olamine)_SNU-423 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Osimertinib (mesylate)_SNU-423 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Osimertinib (mesylate)_SNU-423 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Atazanavir (sulfate)_SNU-423 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Atazanavir (sulfate)_SNU-423 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Berbamine (dihydrochloride)_SNU-423 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Berbamine (dihydrochloride)_SNU-423 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Phenytoin (sodium)_SNU-423 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Phenytoin (sodium)_SNU-423 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
LY-2584702 (tosylate salt)_SNU-423 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the LY-2584702 (tosylate salt)_SNU-423 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
S-Adenosyl-L-methionine (disulfate tosylate)_SNU-1 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the S-Adenosyl-L-methionine (disulfate tosylate)_SNU-1 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Edoxaban (tosylate monohydrate)_SNU-423 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Edoxaban (tosylate monohydrate)_SNU-423 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Berberine (chloride hydrate)_SNU-423 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Berberine (chloride hydrate)_SNU-423 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Fostamatinib (disodium hexahydrate)_SNU-423 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Fostamatinib (disodium hexahydrate)_SNU-423 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Pravastatin (sodium)_SNU-423 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Pravastatin (sodium)_SNU-423 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Ouabain (Octahydrate)_SNU-1 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Ouabain (Octahydrate)_SNU-1 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Palmatine (chloride)_SNU-1 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Palmatine (chloride)_SNU-1 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Quinidine (15% dihydroquinidine)_SNU-1 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Quinidine (15% dihydroquinidine)_SNU-1 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Almonertinib (mesylate)_SNU-1 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Almonertinib (mesylate)_SNU-1 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Benztropine (mesylate)_SNU-423 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Benztropine (mesylate)_SNU-423 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Goserelin (acetate)_SNU-423 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Goserelin (acetate)_SNU-423 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Pasireotide (acetate)_SNU-1 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Pasireotide (acetate)_SNU-1 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
L-Eflornithine (monohydrochloride)_SNU-423 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the L-Eflornithine (monohydrochloride)_SNU-423 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Benproperine (phosphate)_SNU-423 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Benproperine (phosphate)_SNU-423 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Pasireotide (acetate)_SNU-423 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Pasireotide (acetate)_SNU-423 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Cloxacillin (sodium)_SNU-423 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Cloxacillin (sodium)_SNU-423 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Belumosudil (mesylate)_SNU-423 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Belumosudil (mesylate)_SNU-423 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Nafamostat (mesylate)_SNU-423 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Nafamostat (mesylate)_SNU-423 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Gallic acid (hydrate)_SNU-423 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Gallic acid (hydrate)_SNU-423 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Niclosamide (olamine)_SNU-1 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Niclosamide (olamine)_SNU-1 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Estrone sulfate (potassium)_SNU-423 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Estrone sulfate (potassium)_SNU-423 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Docetaxel (Trihydrate)_SNU-1 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Docetaxel (Trihydrate)_SNU-1 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Rucaparib (phosphate)_SNU-1 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Rucaparib (phosphate)_SNU-1 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Entecavir (monohydrate)_SNU-423 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Entecavir (monohydrate)_SNU-423 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Imiquimod (maleate)_SNU-1 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Imiquimod (maleate)_SNU-1 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
hydrastine hydrochloride-7309 Gene Set From CMAP Signatures of Differentially Expressed Genes for Small Molecules genes differentially expressed following the hydrastine hydrochloride-7309 small molecule perturbation from the CMAP Signatures of Differentially Expressed Genes for Small Molecules dataset.
hydrastine hydrochloride-2889 Gene Set From CMAP Signatures of Differentially Expressed Genes for Small Molecules genes differentially expressed following the hydrastine hydrochloride-2889 small molecule perturbation from the CMAP Signatures of Differentially Expressed Genes for Small Molecules dataset.
hydrastine hydrochloride-1740 Gene Set From CMAP Signatures of Differentially Expressed Genes for Small Molecules genes differentially expressed following the hydrastine hydrochloride-1740 small molecule perturbation from the CMAP Signatures of Differentially Expressed Genes for Small Molecules dataset.
hydrastine hydrochloride-6011 Gene Set From CMAP Signatures of Differentially Expressed Genes for Small Molecules genes differentially expressed following the hydrastine hydrochloride-6011 small molecule perturbation from the CMAP Signatures of Differentially Expressed Genes for Small Molecules dataset.
temocapril hydrochloride Gene Set From CTD Gene-Chemical Interactions genes/proteins interacting with the chemical temocapril hydrochloride from the curated CTD Gene-Chemical Interactions dataset.
4-((2-(1-methyl-2-pyrrolidinyl)ethyl)thio)phenol hydrochloride Gene Set From CTD Gene-Chemical Interactions genes/proteins interacting with the chemical 4-((2-(1-methyl-2-pyrrolidinyl)ethyl)thio)phenol hydrochloride from the curated CTD Gene-Chemical Interactions dataset.
adrogolide hydrochloride Gene Set From CTD Gene-Chemical Interactions genes/proteins interacting with the chemical adrogolide hydrochloride from the curated CTD Gene-Chemical Interactions dataset.
2-(5-benzo(1,3)dioxol-5-yl-2-tert-butyl-3H-imidazol-4-yl)-6-methylpyridine hydrochloride Gene Set From CTD Gene-Chemical Interactions genes/proteins interacting with the chemical 2-(5-benzo(1,3)dioxol-5-yl-2-tert-butyl-3H-imidazol-4-yl)-6-methylpyridine hydrochloride from the curated CTD Gene-Chemical Interactions dataset.
Tiapamil Hydrochloride Gene Set From CTD Gene-Chemical Interactions genes/proteins interacting with the chemical Tiapamil Hydrochloride from the curated CTD Gene-Chemical Interactions dataset.
4-amino-1-(6-chloro-2-pyridyl)piperidine hydrochloride Gene Set From CTD Gene-Chemical Interactions genes/proteins interacting with the chemical 4-amino-1-(6-chloro-2-pyridyl)piperidine hydrochloride from the curated CTD Gene-Chemical Interactions dataset.
5-chloro-6-(1-(2-iminopyrrolidinyl) methyl)uracil hydrochloride Gene Set From CTD Gene-Chemical Interactions genes/proteins interacting with the chemical 5-chloro-6-(1-(2-iminopyrrolidinyl) methyl)uracil hydrochloride from the curated CTD Gene-Chemical Interactions dataset.
N-(oxo-5,6-dihydrophenanthridin-2-yl)-N,N-dimethylacetamide hydrochloride Gene Set From CTD Gene-Chemical Interactions genes/proteins interacting with the chemical N-(oxo-5,6-dihydrophenanthridin-2-yl)-N,N-dimethylacetamide hydrochloride from the curated CTD Gene-Chemical Interactions dataset.
6,7-dimethyl-2-(2E)-3-(1-methyl-2-phenyl-1H-pyrrolo(2,3-b)pyridin-3-yl-prop-2-enoyl)-1,2,3,4-tetrahydroisoquinoline hydrochloride Gene Set From CTD Gene-Chemical Interactions genes/proteins interacting with the chemical 6,7-dimethyl-2-(2E)-3-(1-methyl-2-phenyl-1H-pyrrolo(2,3-b)pyridin-3-yl-prop-2-enoyl)-1,2,3,4-tetrahydroisoquinoline hydrochloride from the curated CTD Gene-Chemical Interactions dataset.
(5-fluoro-2-methyl-1-(4-pyridyl)methylene-3-(N-benzyl)-indene)-acetamide hydrochloride Gene Set From CTD Gene-Chemical Interactions genes/proteins interacting with the chemical (5-fluoro-2-methyl-1-(4-pyridyl)methylene-3-(N-benzyl)-indene)-acetamide hydrochloride from the curated CTD Gene-Chemical Interactions dataset.
2-aminomethyl-2-tricyclo(3.3.1.1(1,7))decaneacetic acid hydrochloride Gene Set From CTD Gene-Chemical Interactions genes/proteins interacting with the chemical 2-aminomethyl-2-tricyclo(3.3.1.1(1,7))decaneacetic acid hydrochloride from the curated CTD Gene-Chemical Interactions dataset.
1-((4-fluorobenzoylamino)ethyl)-4-(7-methoxy-1-naphthyl)piperazine hydrochloride Gene Set From CTD Gene-Chemical Interactions genes/proteins interacting with the chemical 1-((4-fluorobenzoylamino)ethyl)-4-(7-methoxy-1-naphthyl)piperazine hydrochloride from the curated CTD Gene-Chemical Interactions dataset.
N-HYDROXY-2(R)-[[(4-METHOXYPHENYL)SULFONYL](3-PICOLYL)AMINO]-3-METHYLBUTANAMIDE HYDROCHLORIDE Gene Set From DrugBank Drug Targets interacting proteins for the N-HYDROXY-2(R)-[[(4-METHOXYPHENYL)SULFONYL](3-PICOLYL)AMINO]-3-METHYLBUTANAMIDE HYDROCHLORIDE drug from the curated DrugBank Drug Targets dataset.
betaxolol hydrochloride efficacy Gene Set From GAD Gene-Disease Associations genes associated with the disease betaxolol hydrochloride efficacy in GWAS and other genetic association datasets from the GAD Gene-Disease Associations dataset.
hydrochloride Gene Set From GeneRIF Biological Term Annotations genes co-occuring with the biological term hydrochloride in literature-supported statements describing functions of genes from the GeneRIF Biological Term Annotations dataset.
Serum tamsulosin hydrochloride concentration Gene Set From GWAS Catalog SNP-Phenotype Associations genes associated with the Serum tamsulosin hydrochloride concentration phenotype in GWAS datasets from the GWAS Catalog SNP-Phenotype Associations dataset.
BRD-M73371355_R(-) Apomorphine hydrochloride hemihydrate_MCF7_6.0_h_10.0_um Gene Set From LINCS L1000 CMAP Signatures of Differentially Expressed Genes for Small Molecules genes differentially expressed following the BRD-M73371355_R(-) Apomorphine hydrochloride hemihydrate_MCF7_6.0_h_10.0_um small molecule perturbation from the LINCS L1000 CMAP Signatures of Differentially Expressed Genes for Small Molecules dataset.
BRD-A71390734_4-Demethoxydaunorubicin hydrochloride (65)_VCAP_24.0_h_0.08_um Gene Set From LINCS L1000 CMAP Signatures of Differentially Expressed Genes for Small Molecules genes differentially expressed following the BRD-A71390734_4-Demethoxydaunorubicin hydrochloride (65)_VCAP_24.0_h_0.08_um small molecule perturbation from the LINCS L1000 CMAP Signatures of Differentially Expressed Genes for Small Molecules dataset.
BRD-A71390734_4-Demethoxydaunorubicin hydrochloride (65)_HT29_6.0_h_0.08_um Gene Set From LINCS L1000 CMAP Signatures of Differentially Expressed Genes for Small Molecules genes differentially expressed following the BRD-A71390734_4-Demethoxydaunorubicin hydrochloride (65)_HT29_6.0_h_0.08_um small molecule perturbation from the LINCS L1000 CMAP Signatures of Differentially Expressed Genes for Small Molecules dataset.
BRD-A71390734_4-Demethoxydaunorubicin hydrochloride (65)_VCAP_6.0_h_0.08_um Gene Set From LINCS L1000 CMAP Signatures of Differentially Expressed Genes for Small Molecules genes differentially expressed following the BRD-A71390734_4-Demethoxydaunorubicin hydrochloride (65)_VCAP_6.0_h_0.08_um small molecule perturbation from the LINCS L1000 CMAP Signatures of Differentially Expressed Genes for Small Molecules dataset.
BRD-A71390734_4-Demethoxydaunorubicin hydrochloride (65)_RMUGS_6.0_h_0.08_um Gene Set From LINCS L1000 CMAP Signatures of Differentially Expressed Genes for Small Molecules genes differentially expressed following the BRD-A71390734_4-Demethoxydaunorubicin hydrochloride (65)_RMUGS_6.0_h_0.08_um small molecule perturbation from the LINCS L1000 CMAP Signatures of Differentially Expressed Genes for Small Molecules dataset.
BRD-K08547377_Irinotecan hydrochloride trihydrate_MCF7_6.0_h_10.0_um Gene Set From LINCS L1000 CMAP Signatures of Differentially Expressed Genes for Small Molecules genes differentially expressed following the BRD-K08547377_Irinotecan hydrochloride trihydrate_MCF7_6.0_h_10.0_um small molecule perturbation from the LINCS L1000 CMAP Signatures of Differentially Expressed Genes for Small Molecules dataset.
BRD-A71390734_4-Demethoxydaunorubicin hydrochloride (65)_PC3_24.0_h_0.08_um Gene Set From LINCS L1000 CMAP Signatures of Differentially Expressed Genes for Small Molecules genes differentially expressed following the BRD-A71390734_4-Demethoxydaunorubicin hydrochloride (65)_PC3_24.0_h_0.08_um small molecule perturbation from the LINCS L1000 CMAP Signatures of Differentially Expressed Genes for Small Molecules dataset.
BRD-A71390734_4-Demethoxydaunorubicin hydrochloride (65)_PL21_6.0_h_0.08_um Gene Set From LINCS L1000 CMAP Signatures of Differentially Expressed Genes for Small Molecules genes differentially expressed following the BRD-A71390734_4-Demethoxydaunorubicin hydrochloride (65)_PL21_6.0_h_0.08_um small molecule perturbation from the LINCS L1000 CMAP Signatures of Differentially Expressed Genes for Small Molecules dataset.
BRD-A71390734_4-Demethoxydaunorubicin hydrochloride (65)_SW620_6.0_h_0.08_um Gene Set From LINCS L1000 CMAP Signatures of Differentially Expressed Genes for Small Molecules genes differentially expressed following the BRD-A71390734_4-Demethoxydaunorubicin hydrochloride (65)_SW620_6.0_h_0.08_um small molecule perturbation from the LINCS L1000 CMAP Signatures of Differentially Expressed Genes for Small Molecules dataset.
BRD-K08547377_Irinotecan hydrochloride trihydrate_MCF7_24.0_h_10.0_um Gene Set From LINCS L1000 CMAP Signatures of Differentially Expressed Genes for Small Molecules genes differentially expressed following the BRD-K08547377_Irinotecan hydrochloride trihydrate_MCF7_24.0_h_10.0_um small molecule perturbation from the LINCS L1000 CMAP Signatures of Differentially Expressed Genes for Small Molecules dataset.
BRD-A71390734_4-Demethoxydaunorubicin hydrochloride (65)_U937_6.0_h_0.08_um Gene Set From LINCS L1000 CMAP Signatures of Differentially Expressed Genes for Small Molecules genes differentially expressed following the BRD-A71390734_4-Demethoxydaunorubicin hydrochloride (65)_U937_6.0_h_0.08_um small molecule perturbation from the LINCS L1000 CMAP Signatures of Differentially Expressed Genes for Small Molecules dataset.
BRD-K99257182_Quinidine hydrochloride monohydrate_MCF7_6.0_h_10.0_um Gene Set From LINCS L1000 CMAP Signatures of Differentially Expressed Genes for Small Molecules genes differentially expressed following the BRD-K99257182_Quinidine hydrochloride monohydrate_MCF7_6.0_h_10.0_um small molecule perturbation from the LINCS L1000 CMAP Signatures of Differentially Expressed Genes for Small Molecules dataset.
BRD-K08547377_Irinotecan hydrochloride trihydrate_PC3_24.0_h_10.0_um Gene Set From LINCS L1000 CMAP Signatures of Differentially Expressed Genes for Small Molecules genes differentially expressed following the BRD-K08547377_Irinotecan hydrochloride trihydrate_PC3_24.0_h_10.0_um small molecule perturbation from the LINCS L1000 CMAP Signatures of Differentially Expressed Genes for Small Molecules dataset.
BRD-A71390734_4-Demethoxydaunorubicin hydrochloride (65)_HCC15_6.0_h_0.08_um Gene Set From LINCS L1000 CMAP Signatures of Differentially Expressed Genes for Small Molecules genes differentially expressed following the BRD-A71390734_4-Demethoxydaunorubicin hydrochloride (65)_HCC15_6.0_h_0.08_um small molecule perturbation from the LINCS L1000 CMAP Signatures of Differentially Expressed Genes for Small Molecules dataset.
BRD-A71390734_4-Demethoxydaunorubicin hydrochloride (65)_HCC515_24.0_h_0.08_um Gene Set From LINCS L1000 CMAP Signatures of Differentially Expressed Genes for Small Molecules genes differentially expressed following the BRD-A71390734_4-Demethoxydaunorubicin hydrochloride (65)_HCC515_24.0_h_0.08_um small molecule perturbation from the LINCS L1000 CMAP Signatures of Differentially Expressed Genes for Small Molecules dataset.
BRD-A71390734_4-Demethoxydaunorubicin hydrochloride (65)_NCIH2073_6.0_h_0.08_um Gene Set From LINCS L1000 CMAP Signatures of Differentially Expressed Genes for Small Molecules genes differentially expressed following the BRD-A71390734_4-Demethoxydaunorubicin hydrochloride (65)_NCIH2073_6.0_h_0.08_um small molecule perturbation from the LINCS L1000 CMAP Signatures of Differentially Expressed Genes for Small Molecules dataset.
BRD-A71390734_4-Demethoxydaunorubicin hydrochloride (65)_OV7_6.0_h_0.08_um Gene Set From LINCS L1000 CMAP Signatures of Differentially Expressed Genes for Small Molecules genes differentially expressed following the BRD-A71390734_4-Demethoxydaunorubicin hydrochloride (65)_OV7_6.0_h_0.08_um small molecule perturbation from the LINCS L1000 CMAP Signatures of Differentially Expressed Genes for Small Molecules dataset.
BRD-A71390734_4-Demethoxydaunorubicin hydrochloride (65)_A549_6.0_h_0.08_um Gene Set From LINCS L1000 CMAP Signatures of Differentially Expressed Genes for Small Molecules genes differentially expressed following the BRD-A71390734_4-Demethoxydaunorubicin hydrochloride (65)_A549_6.0_h_0.08_um small molecule perturbation from the LINCS L1000 CMAP Signatures of Differentially Expressed Genes for Small Molecules dataset.
BRD-A71390734_4-Demethoxydaunorubicin hydrochloride (65)_WSUDLCL2_6.0_h_0.08_um Gene Set From LINCS L1000 CMAP Signatures of Differentially Expressed Genes for Small Molecules genes differentially expressed following the BRD-A71390734_4-Demethoxydaunorubicin hydrochloride (65)_WSUDLCL2_6.0_h_0.08_um small molecule perturbation from the LINCS L1000 CMAP Signatures of Differentially Expressed Genes for Small Molecules dataset.
BRD-A71390734_4-Demethoxydaunorubicin hydrochloride (65)_MCF7_6.0_h_0.08_um Gene Set From LINCS L1000 CMAP Signatures of Differentially Expressed Genes for Small Molecules genes differentially expressed following the BRD-A71390734_4-Demethoxydaunorubicin hydrochloride (65)_MCF7_6.0_h_0.08_um small molecule perturbation from the LINCS L1000 CMAP Signatures of Differentially Expressed Genes for Small Molecules dataset.
BRD-A71390734_4-Demethoxydaunorubicin hydrochloride (65)_JHUEM2_6.0_h_0.08_um Gene Set From LINCS L1000 CMAP Signatures of Differentially Expressed Genes for Small Molecules genes differentially expressed following the BRD-A71390734_4-Demethoxydaunorubicin hydrochloride (65)_JHUEM2_6.0_h_0.08_um small molecule perturbation from the LINCS L1000 CMAP Signatures of Differentially Expressed Genes for Small Molecules dataset.
BRD-K47448802_ethyl 4-(2-benzamidoethylamino)piperidine-1-carboxylate hydrochloride Vanderbilt_Probe_3_HEPG2_6.0_h_10.0_um Gene Set From LINCS L1000 CMAP Signatures of Differentially Expressed Genes for Small Molecules genes differentially expressed following the BRD-K47448802_ethyl 4-(2-benzamidoethylamino)piperidine-1-carboxylate hydrochloride Vanderbilt_Probe_3_HEPG2_6.0_h_10.0_um small molecule perturbation from the LINCS L1000 CMAP Signatures of Differentially Expressed Genes for Small Molecules dataset.
BRD-K69231968_ethyl 4-(2-(3,4-difluorobenzamido)ethylamino)piperidine-1-carboxylate hydrochloride Vanderbilt_Probe_6_VCAP_24.0_h_10.0_um Gene Set From LINCS L1000 CMAP Signatures of Differentially Expressed Genes for Small Molecules genes differentially expressed following the BRD-K69231968_ethyl 4-(2-(3,4-difluorobenzamido)ethylamino)piperidine-1-carboxylate hydrochloride Vanderbilt_Probe_6_VCAP_24.0_h_10.0_um small molecule perturbation from the LINCS L1000 CMAP Signatures of Differentially Expressed Genes for Small Molecules dataset.
BRD-A71390734_4-Demethoxydaunorubicin hydrochloride (65)_A549_24.0_h_0.08_um Gene Set From LINCS L1000 CMAP Signatures of Differentially Expressed Genes for Small Molecules genes differentially expressed following the BRD-A71390734_4-Demethoxydaunorubicin hydrochloride (65)_A549_24.0_h_0.08_um small molecule perturbation from the LINCS L1000 CMAP Signatures of Differentially Expressed Genes for Small Molecules dataset.
BRD-A71390734_4-Demethoxydaunorubicin hydrochloride (65)_HEPG2_6.0_h_0.08_um Gene Set From LINCS L1000 CMAP Signatures of Differentially Expressed Genes for Small Molecules genes differentially expressed following the BRD-A71390734_4-Demethoxydaunorubicin hydrochloride (65)_HEPG2_6.0_h_0.08_um small molecule perturbation from the LINCS L1000 CMAP Signatures of Differentially Expressed Genes for Small Molecules dataset.
BRD-A71390734_4-Demethoxydaunorubicin hydrochloride (65)_MCF7_24.0_h_0.08_um Gene Set From LINCS L1000 CMAP Signatures of Differentially Expressed Genes for Small Molecules genes differentially expressed following the BRD-A71390734_4-Demethoxydaunorubicin hydrochloride (65)_MCF7_24.0_h_0.08_um small molecule perturbation from the LINCS L1000 CMAP Signatures of Differentially Expressed Genes for Small Molecules dataset.
BRD-A71390734_4-Demethoxydaunorubicin hydrochloride (65)_HCC515_6.0_h_0.08_um Gene Set From LINCS L1000 CMAP Signatures of Differentially Expressed Genes for Small Molecules genes differentially expressed following the BRD-A71390734_4-Demethoxydaunorubicin hydrochloride (65)_HCC515_6.0_h_0.08_um small molecule perturbation from the LINCS L1000 CMAP Signatures of Differentially Expressed Genes for Small Molecules dataset.
BRD-A71390734_4-Demethoxydaunorubicin hydrochloride (65)_SKMEL1_6.0_h_0.08_um Gene Set From LINCS L1000 CMAP Signatures of Differentially Expressed Genes for Small Molecules genes differentially expressed following the BRD-A71390734_4-Demethoxydaunorubicin hydrochloride (65)_SKMEL1_6.0_h_0.08_um small molecule perturbation from the LINCS L1000 CMAP Signatures of Differentially Expressed Genes for Small Molecules dataset.
BRD-A71390734_4-Demethoxydaunorubicin hydrochloride (65)_A375_6.0_h_0.08_um Gene Set From LINCS L1000 CMAP Signatures of Differentially Expressed Genes for Small Molecules genes differentially expressed following the BRD-A71390734_4-Demethoxydaunorubicin hydrochloride (65)_A375_6.0_h_0.08_um small molecule perturbation from the LINCS L1000 CMAP Signatures of Differentially Expressed Genes for Small Molecules dataset.
BRD-A71390734_4-Demethoxydaunorubicin hydrochloride (65)_DV90_6.0_h_0.08_um Gene Set From LINCS L1000 CMAP Signatures of Differentially Expressed Genes for Small Molecules genes differentially expressed following the BRD-A71390734_4-Demethoxydaunorubicin hydrochloride (65)_DV90_6.0_h_0.08_um small molecule perturbation from the LINCS L1000 CMAP Signatures of Differentially Expressed Genes for Small Molecules dataset.
BRD-A71390734_4-Demethoxydaunorubicin hydrochloride (65)_NCIH596_6.0_h_0.08_um Gene Set From LINCS L1000 CMAP Signatures of Differentially Expressed Genes for Small Molecules genes differentially expressed following the BRD-A71390734_4-Demethoxydaunorubicin hydrochloride (65)_NCIH596_6.0_h_0.08_um small molecule perturbation from the LINCS L1000 CMAP Signatures of Differentially Expressed Genes for Small Molecules dataset.
BRD-A71390734_4-Demethoxydaunorubicin hydrochloride (65)_HT29_24.0_h_0.08_um Gene Set From LINCS L1000 CMAP Signatures of Differentially Expressed Genes for Small Molecules genes differentially expressed following the BRD-A71390734_4-Demethoxydaunorubicin hydrochloride (65)_HT29_24.0_h_0.08_um small molecule perturbation from the LINCS L1000 CMAP Signatures of Differentially Expressed Genes for Small Molecules dataset.
BRD-A71390734_4-Demethoxydaunorubicin hydrochloride (65)_HA1E_24.0_h_0.08_um Gene Set From LINCS L1000 CMAP Signatures of Differentially Expressed Genes for Small Molecules genes differentially expressed following the BRD-A71390734_4-Demethoxydaunorubicin hydrochloride (65)_HA1E_24.0_h_0.08_um small molecule perturbation from the LINCS L1000 CMAP Signatures of Differentially Expressed Genes for Small Molecules dataset.
BRD-A71390734_4-Demethoxydaunorubicin hydrochloride (65)_MDST8_6.0_h_0.08_um Gene Set From LINCS L1000 CMAP Signatures of Differentially Expressed Genes for Small Molecules genes differentially expressed following the BRD-A71390734_4-Demethoxydaunorubicin hydrochloride (65)_MDST8_6.0_h_0.08_um small molecule perturbation from the LINCS L1000 CMAP Signatures of Differentially Expressed Genes for Small Molecules dataset.
BRD-A71390734_4-Demethoxydaunorubicin hydrochloride (65)_HCT116_6.0_h_0.08_um Gene Set From LINCS L1000 CMAP Signatures of Differentially Expressed Genes for Small Molecules genes differentially expressed following the BRD-A71390734_4-Demethoxydaunorubicin hydrochloride (65)_HCT116_6.0_h_0.08_um small molecule perturbation from the LINCS L1000 CMAP Signatures of Differentially Expressed Genes for Small Molecules dataset.
BRD-A71390734_4-Demethoxydaunorubicin hydrochloride (65)_HA1E_6.0_h_0.08_um Gene Set From LINCS L1000 CMAP Signatures of Differentially Expressed Genes for Small Molecules genes differentially expressed following the BRD-A71390734_4-Demethoxydaunorubicin hydrochloride (65)_HA1E_6.0_h_0.08_um small molecule perturbation from the LINCS L1000 CMAP Signatures of Differentially Expressed Genes for Small Molecules dataset.
BRD-A71390734_4-Demethoxydaunorubicin hydrochloride (65)_SKM1_6.0_h_0.08_um Gene Set From LINCS L1000 CMAP Signatures of Differentially Expressed Genes for Small Molecules genes differentially expressed following the BRD-A71390734_4-Demethoxydaunorubicin hydrochloride (65)_SKM1_6.0_h_0.08_um small molecule perturbation from the LINCS L1000 CMAP Signatures of Differentially Expressed Genes for Small Molecules dataset.
BRD-A71390734_4-Demethoxydaunorubicin hydrochloride (65)_LOVO_6.0_h_0.08_um Gene Set From LINCS L1000 CMAP Signatures of Differentially Expressed Genes for Small Molecules genes differentially expressed following the BRD-A71390734_4-Demethoxydaunorubicin hydrochloride (65)_LOVO_6.0_h_0.08_um small molecule perturbation from the LINCS L1000 CMAP Signatures of Differentially Expressed Genes for Small Molecules dataset.
BRD-A71390734_4-Demethoxydaunorubicin hydrochloride (65)_AGS_6.0_h_0.08_um Gene Set From LINCS L1000 CMAP Signatures of Differentially Expressed Genes for Small Molecules genes differentially expressed following the BRD-A71390734_4-Demethoxydaunorubicin hydrochloride (65)_AGS_6.0_h_0.08_um small molecule perturbation from the LINCS L1000 CMAP Signatures of Differentially Expressed Genes for Small Molecules dataset.
BRD-A71390734_4-Demethoxydaunorubicin hydrochloride (65)_A375_24.0_h_0.08_um Gene Set From LINCS L1000 CMAP Signatures of Differentially Expressed Genes for Small Molecules genes differentially expressed following the BRD-A71390734_4-Demethoxydaunorubicin hydrochloride (65)_A375_24.0_h_0.08_um small molecule perturbation from the LINCS L1000 CMAP Signatures of Differentially Expressed Genes for Small Molecules dataset.
BRD-A71390734_4-Demethoxydaunorubicin hydrochloride (65)_A673_6.0_h_0.08_um Gene Set From LINCS L1000 CMAP Signatures of Differentially Expressed Genes for Small Molecules genes differentially expressed following the BRD-A71390734_4-Demethoxydaunorubicin hydrochloride (65)_A673_6.0_h_0.08_um small molecule perturbation from the LINCS L1000 CMAP Signatures of Differentially Expressed Genes for Small Molecules dataset.
BRD-A71390734_4-Demethoxydaunorubicin hydrochloride (65)_SKLU1_6.0_h_0.08_um Gene Set From LINCS L1000 CMAP Signatures of Differentially Expressed Genes for Small Molecules genes differentially expressed following the BRD-A71390734_4-Demethoxydaunorubicin hydrochloride (65)_SKLU1_6.0_h_0.08_um small molecule perturbation from the LINCS L1000 CMAP Signatures of Differentially Expressed Genes for Small Molecules dataset.
BCI-hydrochloride Gene Set From LINCS L1000 CMAP Chemical Perturbation Consensus Signatures genes differentially expressed following the BCI-hydrochloride small molecule perturbation from the LINCS L1000 CMAP Chemical Perturbation Consensus Signatures dataset.
Doxorubicin (hydrochloride)_COLO 205 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Doxorubicin (hydrochloride)_COLO 205 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Irinotecan (hydrochloride)_HepG2/C3A Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Irinotecan (hydrochloride)_HepG2/C3A drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Methyl aminolevulinate (hydrochloride)_HepG2/C3A Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Methyl aminolevulinate (hydrochloride)_HepG2/C3A drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Pyridoxine (hydrochloride)_C32 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Pyridoxine (hydrochloride)_C32 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Tetracycline (hydrochloride)_C32 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Tetracycline (hydrochloride)_C32 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Esmolol (hydrochloride)_C32 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Esmolol (hydrochloride)_C32 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Norepinephrine (hydrochloride)_HepG2/C3A Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Norepinephrine (hydrochloride)_HepG2/C3A drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Bestatin (hydrochloride)_C32 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Bestatin (hydrochloride)_C32 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Idarubicin (hydrochloride)_C32 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Idarubicin (hydrochloride)_C32 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Bestatin (hydrochloride)_HepG2/C3A Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Bestatin (hydrochloride)_HepG2/C3A drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Imiquimod (hydrochloride)_C32 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Imiquimod (hydrochloride)_C32 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
(R)-Verapamil (hydrochloride)_HepG2/C3A Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the (R)-Verapamil (hydrochloride)_HepG2/C3A drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Phenylephrine (hydrochloride)_C32 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Phenylephrine (hydrochloride)_C32 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Fingolimod (hydrochloride)_C32 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Fingolimod (hydrochloride)_C32 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Doxorubicin (hydrochloride)_HepG2/C3A Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Doxorubicin (hydrochloride)_HepG2/C3A drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Pexidartinib (hydrochloride)_C32 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Pexidartinib (hydrochloride)_C32 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
(R)-Verapamil (hydrochloride)_NCI-H460 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the (R)-Verapamil (hydrochloride)_NCI-H460 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Clonidine (hydrochloride)_A549 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Clonidine (hydrochloride)_A549 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Almonertinib (hydrochloride)_A549 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Almonertinib (hydrochloride)_A549 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Norepinephrine (hydrochloride)_NCI-H1792 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Norepinephrine (hydrochloride)_NCI-H1792 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Ropivacaine (hydrochloride monohydrate)_NCI-H1792 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Ropivacaine (hydrochloride monohydrate)_NCI-H1792 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Cysteamine (hydrochloride)_A549 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Cysteamine (hydrochloride)_A549 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Doxorubicin (hydrochloride)_NCI-H1792 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Doxorubicin (hydrochloride)_NCI-H1792 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Idarubicin (hydrochloride)_HepG2/C3A Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Idarubicin (hydrochloride)_HepG2/C3A drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Levobupivacaine (hydrochloride)_NCI-H1792 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Levobupivacaine (hydrochloride)_NCI-H1792 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Methyl aminolevulinate (hydrochloride)_NCI-H1792 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Methyl aminolevulinate (hydrochloride)_NCI-H1792 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Irinotecan (hydrochloride)_MIA PaCa-2 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Irinotecan (hydrochloride)_MIA PaCa-2 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Crizotinib (hydrochloride)_RKO Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Crizotinib (hydrochloride)_RKO drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Crizotinib (hydrochloride)_LoVo Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Crizotinib (hydrochloride)_LoVo drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Crizotinib (hydrochloride)_MIA PaCa-2 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Crizotinib (hydrochloride)_MIA PaCa-2 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Crizotinib (hydrochloride)_A498 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Crizotinib (hydrochloride)_A498 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Crizotinib (hydrochloride)_SW480 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Crizotinib (hydrochloride)_SW480 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Irinotecan (hydrochloride)_SW480 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Irinotecan (hydrochloride)_SW480 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Clonidine (hydrochloride)_LoVo Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Clonidine (hydrochloride)_LoVo drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Irinotecan (hydrochloride)_BT-474 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Irinotecan (hydrochloride)_BT-474 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Crizotinib (hydrochloride)_HT-29 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Crizotinib (hydrochloride)_HT-29 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Doxorubicin (hydrochloride)_AN3 CA Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Doxorubicin (hydrochloride)_AN3 CA drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Ivabradine (hydrochloride)_A-427 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Ivabradine (hydrochloride)_A-427 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Crizotinib (hydrochloride)_LOX-IMVI Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Crizotinib (hydrochloride)_LOX-IMVI drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Pyridoxine (hydrochloride)_HEC-1-A Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Pyridoxine (hydrochloride)_HEC-1-A drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Clonidine (hydrochloride)_RKO Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Clonidine (hydrochloride)_RKO drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Bestatin (hydrochloride)_HEC-1-A Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Bestatin (hydrochloride)_HEC-1-A drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Pyridoxine (hydrochloride)_SW480 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Pyridoxine (hydrochloride)_SW480 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Crizotinib (hydrochloride)_SK-MEL-2 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Crizotinib (hydrochloride)_SK-MEL-2 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Cytarabine (hydrochloride)_HepG2/C3A Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Cytarabine (hydrochloride)_HepG2/C3A drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Imiquimod (hydrochloride)_HepG2/C3A Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Imiquimod (hydrochloride)_HepG2/C3A drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Levobupivacaine (hydrochloride)_HepG2/C3A Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Levobupivacaine (hydrochloride)_HepG2/C3A drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Epirubicin (hydrochloride)_COLO 205 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Epirubicin (hydrochloride)_COLO 205 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Cytarabine (hydrochloride)_hTERT-HPNE Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Cytarabine (hydrochloride)_hTERT-HPNE drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Phenylephrine (hydrochloride)_hTERT-HPNE Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Phenylephrine (hydrochloride)_hTERT-HPNE drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Tetracycline (hydrochloride)_J82 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Tetracycline (hydrochloride)_J82 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Irinotecan (hydrochloride)_A498 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Irinotecan (hydrochloride)_A498 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Idarubicin (hydrochloride)_Hs 766T Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Idarubicin (hydrochloride)_Hs 766T drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Tetracycline (hydrochloride)_NCI-H1792 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Tetracycline (hydrochloride)_NCI-H1792 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Imiquimod (hydrochloride)_A-172 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Imiquimod (hydrochloride)_A-172 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Fedratinib (hydrochloride hydrate)_J82 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Fedratinib (hydrochloride hydrate)_J82 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Pexidartinib (hydrochloride)_HepG2/C3A Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Pexidartinib (hydrochloride)_HepG2/C3A drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Imiquimod (hydrochloride)_H4 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Imiquimod (hydrochloride)_H4 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Pexidartinib (hydrochloride)_SW 1088 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Pexidartinib (hydrochloride)_SW 1088 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Ivabradine (hydrochloride)_NCI-H1792 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Ivabradine (hydrochloride)_NCI-H1792 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Lidocaine (hydrochloride)_J82 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Lidocaine (hydrochloride)_J82 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Ivabradine (hydrochloride)_J82 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Ivabradine (hydrochloride)_J82 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Idarubicin (hydrochloride)_A-172 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Idarubicin (hydrochloride)_A-172 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Ivabradine (hydrochloride)_SW 900 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Ivabradine (hydrochloride)_SW 900 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Bestatin (hydrochloride)_LOX-IMVI Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Bestatin (hydrochloride)_LOX-IMVI drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Ivabradine (hydrochloride)_A498 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Ivabradine (hydrochloride)_A498 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Rimonabant (Hydrochloride)_A-172 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Rimonabant (Hydrochloride)_A-172 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Cysteamine (hydrochloride)_J82 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Cysteamine (hydrochloride)_J82 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Lidocaine (hydrochloride)_SW 900 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Lidocaine (hydrochloride)_SW 900 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Procainamide (hydrochloride)_J82 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Procainamide (hydrochloride)_J82 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Dorzolamide (hydrochloride)_A-172 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Dorzolamide (hydrochloride)_A-172 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Irinotecan (hydrochloride)_NCI-H1792 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Irinotecan (hydrochloride)_NCI-H1792 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Tetracycline (hydrochloride)_A498 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Tetracycline (hydrochloride)_A498 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Cysteamine (hydrochloride)_HOP62 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Cysteamine (hydrochloride)_HOP62 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Tetracycline (hydrochloride)_SW 900 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Tetracycline (hydrochloride)_SW 900 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Irinotecan (hydrochloride)_J82 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Irinotecan (hydrochloride)_J82 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Idarubicin (hydrochloride)_RPMI-7951 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Idarubicin (hydrochloride)_RPMI-7951 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Idarubicin (hydrochloride)_hTERT-HPNE Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Idarubicin (hydrochloride)_hTERT-HPNE drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Dorzolamide (hydrochloride)_RPMI-7951 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Dorzolamide (hydrochloride)_RPMI-7951 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Fingolimod (hydrochloride)_A-172 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Fingolimod (hydrochloride)_A-172 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Methyl aminolevulinate (hydrochloride)_A-172 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Methyl aminolevulinate (hydrochloride)_A-172 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Topotecan (hydrochloride)_A498 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Topotecan (hydrochloride)_A498 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Ropivacaine (hydrochloride monohydrate)_A-172 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Ropivacaine (hydrochloride monohydrate)_A-172 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Pyridoxine (hydrochloride)_NCI-H2347 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Pyridoxine (hydrochloride)_NCI-H2347 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Pexidartinib (hydrochloride)_A-172 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Pexidartinib (hydrochloride)_A-172 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
(R)-Verapamil (hydrochloride)_SW 900 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the (R)-Verapamil (hydrochloride)_SW 900 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Cytarabine (hydrochloride)_A-172 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Cytarabine (hydrochloride)_A-172 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
(R)-Verapamil (hydrochloride)_KATO III Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the (R)-Verapamil (hydrochloride)_KATO III drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Topotecan (hydrochloride)_J82 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Topotecan (hydrochloride)_J82 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Phenylephrine (hydrochloride)_A-172 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Phenylephrine (hydrochloride)_A-172 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Topotecan (hydrochloride)_NCI-H1792 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Topotecan (hydrochloride)_NCI-H1792 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Lidocaine (hydrochloride)_NCI-H2347 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Lidocaine (hydrochloride)_NCI-H2347 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
(R)-Verapamil (hydrochloride)_NCI-H1792 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the (R)-Verapamil (hydrochloride)_NCI-H1792 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Tirabrutinib (hydrochloride)_A-172 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Tirabrutinib (hydrochloride)_A-172 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Tetracycline (hydrochloride)_NCI-H2347 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Tetracycline (hydrochloride)_NCI-H2347 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Crizotinib (hydrochloride)_SW 900 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Crizotinib (hydrochloride)_SW 900 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Cytarabine (hydrochloride)_H4 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Cytarabine (hydrochloride)_H4 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Topotecan (hydrochloride)_hTERT-HPNE Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Topotecan (hydrochloride)_hTERT-HPNE drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Levobupivacaine (hydrochloride)_A498 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Levobupivacaine (hydrochloride)_A498 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Tetracycline (hydrochloride)_A-172 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Tetracycline (hydrochloride)_A-172 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Imiquimod (hydrochloride)_NCI-H1792 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Imiquimod (hydrochloride)_NCI-H1792 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Crizotinib (hydrochloride)_COLO 205 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Crizotinib (hydrochloride)_COLO 205 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Lidocaine (hydrochloride)_NCI-H661 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Lidocaine (hydrochloride)_NCI-H661 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Imiquimod (hydrochloride)_J82 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Imiquimod (hydrochloride)_J82 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Crizotinib (hydrochloride)_HepG2/C3A Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Crizotinib (hydrochloride)_HepG2/C3A drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Fedratinib (hydrochloride hydrate)_A-172 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Fedratinib (hydrochloride hydrate)_A-172 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Rimonabant (Hydrochloride)_A498 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Rimonabant (Hydrochloride)_A498 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Bestatin (hydrochloride)_COLO 205 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Bestatin (hydrochloride)_COLO 205 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Rimonabant (Hydrochloride)_NCI-H1792 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Rimonabant (Hydrochloride)_NCI-H1792 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Pexidartinib (hydrochloride)_LOX-IMVI Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Pexidartinib (hydrochloride)_LOX-IMVI drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Tetracycline (hydrochloride)_Hs 766T Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Tetracycline (hydrochloride)_Hs 766T drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Bestatin (hydrochloride)_A549 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Bestatin (hydrochloride)_A549 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Cysteamine (hydrochloride)_A-172 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Cysteamine (hydrochloride)_A-172 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Topotecan (hydrochloride)_HepG2/C3A Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Topotecan (hydrochloride)_HepG2/C3A drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Imiquimod (hydrochloride)_SW 900 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Imiquimod (hydrochloride)_SW 900 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Imiquimod (hydrochloride)_A498 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Imiquimod (hydrochloride)_A498 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Loperamide (hydrochloride)_COLO 205 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Loperamide (hydrochloride)_COLO 205 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Tetracycline (hydrochloride)_COLO 205 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Tetracycline (hydrochloride)_COLO 205 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Bestatin (hydrochloride)_H4 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Bestatin (hydrochloride)_H4 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Crizotinib (hydrochloride)_A-172 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Crizotinib (hydrochloride)_A-172 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Doxorubicin (hydrochloride)_hTERT-HPNE Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Doxorubicin (hydrochloride)_hTERT-HPNE drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Tetracycline (hydrochloride)_SW 1088 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Tetracycline (hydrochloride)_SW 1088 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Cysteamine (hydrochloride)_hTERT-HPNE Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Cysteamine (hydrochloride)_hTERT-HPNE drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
(R)-Verapamil (hydrochloride)_Hs 766T Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the (R)-Verapamil (hydrochloride)_Hs 766T drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Methyl aminolevulinate (hydrochloride)_J82 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Methyl aminolevulinate (hydrochloride)_J82 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Dorzolamide (hydrochloride)_NCI-H2347 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Dorzolamide (hydrochloride)_NCI-H2347 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Cysteamine (hydrochloride)_SW480 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Cysteamine (hydrochloride)_SW480 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Pexidartinib (hydrochloride)_NCI-H1792 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Pexidartinib (hydrochloride)_NCI-H1792 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Phenylephrine (hydrochloride)_A498 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Phenylephrine (hydrochloride)_A498 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Ivabradine (hydrochloride)_HepG2/C3A Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Ivabradine (hydrochloride)_HepG2/C3A drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Ropivacaine (hydrochloride monohydrate)_J82 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Ropivacaine (hydrochloride monohydrate)_J82 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Pexidartinib (hydrochloride)_J82 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Pexidartinib (hydrochloride)_J82 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Topotecan (hydrochloride)_A-172 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Topotecan (hydrochloride)_A-172 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Pexidartinib (hydrochloride)_SW 900 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Pexidartinib (hydrochloride)_SW 900 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Cytarabine (hydrochloride)_J82 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Cytarabine (hydrochloride)_J82 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
(R)-Verapamil (hydrochloride)_A-172 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the (R)-Verapamil (hydrochloride)_A-172 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Cytarabine (hydrochloride)_NCI-H1792 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Cytarabine (hydrochloride)_NCI-H1792 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Pexidartinib (hydrochloride)_A498 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Pexidartinib (hydrochloride)_A498 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Phenylephrine (hydrochloride)_NCI-H1792 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Phenylephrine (hydrochloride)_NCI-H1792 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Fedratinib (hydrochloride hydrate)_hTERT-HPNE Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Fedratinib (hydrochloride hydrate)_hTERT-HPNE drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Almonertinib (hydrochloride)_NCI-H2347 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Almonertinib (hydrochloride)_NCI-H2347 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Lidocaine (hydrochloride)_RPMI-7951 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Lidocaine (hydrochloride)_RPMI-7951 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Ivabradine (hydrochloride)_hTERT-HPNE Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Ivabradine (hydrochloride)_hTERT-HPNE drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
(R)-Verapamil (hydrochloride)_H4 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the (R)-Verapamil (hydrochloride)_H4 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Topotecan (hydrochloride)_H4 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Topotecan (hydrochloride)_H4 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Ivabradine (hydrochloride)_RPMI-7951 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Ivabradine (hydrochloride)_RPMI-7951 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Doxorubicin (hydrochloride)_A498 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Doxorubicin (hydrochloride)_A498 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Epirubicin (hydrochloride)_SW48 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Epirubicin (hydrochloride)_SW48 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Ivabradine (hydrochloride)_CHP-212 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Ivabradine (hydrochloride)_CHP-212 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Fingolimod (hydrochloride)_COLO 205 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Fingolimod (hydrochloride)_COLO 205 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Phenylephrine (hydrochloride)_COLO 205 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Phenylephrine (hydrochloride)_COLO 205 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Imiquimod (hydrochloride)_hTERT-HPNE Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Imiquimod (hydrochloride)_hTERT-HPNE drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Procainamide (hydrochloride)_HepG2/C3A Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Procainamide (hydrochloride)_HepG2/C3A drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Doxorubicin (hydrochloride)_SW 1271 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Doxorubicin (hydrochloride)_SW 1271 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Idarubicin (hydrochloride)_KATO III Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Idarubicin (hydrochloride)_KATO III drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Cytarabine (hydrochloride)_A549 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Cytarabine (hydrochloride)_A549 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Epirubicin (hydrochloride)_A549 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Epirubicin (hydrochloride)_A549 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Doxorubicin (hydrochloride)_A549 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Doxorubicin (hydrochloride)_A549 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Rimonabant (Hydrochloride)_NCI-H460 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Rimonabant (Hydrochloride)_NCI-H460 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Esmolol (hydrochloride)_KATO III Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Esmolol (hydrochloride)_KATO III drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Fingolimod (hydrochloride)_BT-474 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Fingolimod (hydrochloride)_BT-474 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Imiquimod (hydrochloride)_HT-29 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Imiquimod (hydrochloride)_HT-29 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Cysteamine (hydrochloride)_KATO III Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Cysteamine (hydrochloride)_KATO III drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Rimonabant (Hydrochloride)_HEC-1-A Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Rimonabant (Hydrochloride)_HEC-1-A drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Methyl aminolevulinate (hydrochloride)_HT-29 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Methyl aminolevulinate (hydrochloride)_HT-29 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Lidocaine (hydrochloride)_HEC-1-A Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Lidocaine (hydrochloride)_HEC-1-A drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Topotecan (hydrochloride)_BT-474 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Topotecan (hydrochloride)_BT-474 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Lidocaine (hydrochloride)_HT-29 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Lidocaine (hydrochloride)_HT-29 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Lidocaine (hydrochloride)_COLO 205 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Lidocaine (hydrochloride)_COLO 205 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Crizotinib (hydrochloride)_HEC-1-A Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Crizotinib (hydrochloride)_HEC-1-A drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Ropivacaine (hydrochloride monohydrate)_KATO III Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Ropivacaine (hydrochloride monohydrate)_KATO III drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Cysteamine (hydrochloride)_BT-474 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Cysteamine (hydrochloride)_BT-474 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
(R)-Verapamil (hydrochloride)_SHP-77 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the (R)-Verapamil (hydrochloride)_SHP-77 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Procainamide (hydrochloride)_A-172 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Procainamide (hydrochloride)_A-172 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Clonidine (hydrochloride)_HepG2/C3A Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Clonidine (hydrochloride)_HepG2/C3A drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Pyridoxine (hydrochloride)_HCT15 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Pyridoxine (hydrochloride)_HCT15 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Crizotinib (hydrochloride)_J82 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Crizotinib (hydrochloride)_J82 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Rimonabant (Hydrochloride)_A-427 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Rimonabant (Hydrochloride)_A-427 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Tirabrutinib (hydrochloride)_AN3 CA Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Tirabrutinib (hydrochloride)_AN3 CA drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Tirabrutinib (hydrochloride)_SHP-77 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Tirabrutinib (hydrochloride)_SHP-77 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Imiquimod (hydrochloride)_COLO 205 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Imiquimod (hydrochloride)_COLO 205 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Epirubicin (hydrochloride)_HEC-1-A Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Epirubicin (hydrochloride)_HEC-1-A drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Lidocaine (hydrochloride)_LoVo Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Lidocaine (hydrochloride)_LoVo drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Pyridoxine (hydrochloride)_NCI-H2122 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Pyridoxine (hydrochloride)_NCI-H2122 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Tetracycline (hydrochloride)_KATO III Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Tetracycline (hydrochloride)_KATO III drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Ivabradine (hydrochloride)_LoVo Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Ivabradine (hydrochloride)_LoVo drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Pexidartinib (hydrochloride)_BT-474 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Pexidartinib (hydrochloride)_BT-474 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Clonidine (hydrochloride)_BT-474 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Clonidine (hydrochloride)_BT-474 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Tetracycline (hydrochloride)_LoVo Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Tetracycline (hydrochloride)_LoVo drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Pyridoxine (hydrochloride)_KATO III Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Pyridoxine (hydrochloride)_KATO III drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Lidocaine (hydrochloride)_NCI-H2122 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Lidocaine (hydrochloride)_NCI-H2122 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Loperamide (hydrochloride)_LoVo Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Loperamide (hydrochloride)_LoVo drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
(R)-Verapamil (hydrochloride)_LoVo Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the (R)-Verapamil (hydrochloride)_LoVo drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Topotecan (hydrochloride)_LoVo Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Topotecan (hydrochloride)_LoVo drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Norepinephrine (hydrochloride)_LS 180 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Norepinephrine (hydrochloride)_LS 180 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Topotecan (hydrochloride)_LS 180 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Topotecan (hydrochloride)_LS 180 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Almonertinib (hydrochloride)_LoVo Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Almonertinib (hydrochloride)_LoVo drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Levobupivacaine (hydrochloride)_LoVo Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Levobupivacaine (hydrochloride)_LoVo drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Crizotinib (hydrochloride)_RPMI-7951 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Crizotinib (hydrochloride)_RPMI-7951 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Rimonabant (Hydrochloride)_LoVo Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Rimonabant (Hydrochloride)_LoVo drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Pexidartinib (hydrochloride)_LoVo Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Pexidartinib (hydrochloride)_LoVo drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Procainamide (hydrochloride)_LS 180 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Procainamide (hydrochloride)_LS 180 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Epirubicin (hydrochloride)_LoVo Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Epirubicin (hydrochloride)_LoVo drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Pyridoxine (hydrochloride)_BT-474 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Pyridoxine (hydrochloride)_BT-474 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Tetracycline (hydrochloride)_LS 180 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Tetracycline (hydrochloride)_LS 180 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Esmolol (hydrochloride)_LS 180 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Esmolol (hydrochloride)_LS 180 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Lidocaine (hydrochloride)_KATO III Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Lidocaine (hydrochloride)_KATO III drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Pexidartinib (hydrochloride)_COLO 205 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Pexidartinib (hydrochloride)_COLO 205 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Phenylephrine (hydrochloride)_SW480 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Phenylephrine (hydrochloride)_SW480 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Fingolimod (hydrochloride)_LS 180 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Fingolimod (hydrochloride)_LS 180 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Methyl aminolevulinate (hydrochloride)_SW480 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Methyl aminolevulinate (hydrochloride)_SW480 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Levobupivacaine (hydrochloride)_SW480 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Levobupivacaine (hydrochloride)_SW480 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Rimonabant (Hydrochloride)_SW480 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Rimonabant (Hydrochloride)_SW480 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Imiquimod (hydrochloride)_SW480 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Imiquimod (hydrochloride)_SW480 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Imiquimod (hydrochloride)_KATO III Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Imiquimod (hydrochloride)_KATO III drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Topotecan (hydrochloride)_SW480 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Topotecan (hydrochloride)_SW480 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Tetracycline (hydrochloride)_HT-29 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Tetracycline (hydrochloride)_HT-29 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Esmolol (hydrochloride)_HT-29 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Esmolol (hydrochloride)_HT-29 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Crizotinib (hydrochloride)_LS 180 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Crizotinib (hydrochloride)_LS 180 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Topotecan (hydrochloride)_HT-29 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Topotecan (hydrochloride)_HT-29 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Procainamide (hydrochloride)_SW480 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Procainamide (hydrochloride)_SW480 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Cysteamine (hydrochloride)_LS 180 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Cysteamine (hydrochloride)_LS 180 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Fedratinib (hydrochloride hydrate)_COLO 205 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Fedratinib (hydrochloride hydrate)_COLO 205 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Ivabradine (hydrochloride)_SW480 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Ivabradine (hydrochloride)_SW480 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Phenylephrine (hydrochloride)_KATO III Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Phenylephrine (hydrochloride)_KATO III drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Ivabradine (hydrochloride)_LS 180 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Ivabradine (hydrochloride)_LS 180 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Fedratinib (hydrochloride hydrate)_SW480 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Fedratinib (hydrochloride hydrate)_SW480 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Bestatin (hydrochloride)_HT-29 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Bestatin (hydrochloride)_HT-29 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Tetracycline (hydrochloride)_SW480 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Tetracycline (hydrochloride)_SW480 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Fingolimod (hydrochloride)_AsPC-1 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Fingolimod (hydrochloride)_AsPC-1 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Tirabrutinib (hydrochloride)_BT-474 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Tirabrutinib (hydrochloride)_BT-474 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Methyl aminolevulinate (hydrochloride)_Panc 03.27 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Methyl aminolevulinate (hydrochloride)_Panc 03.27 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Tirabrutinib (hydrochloride)_SW48 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Tirabrutinib (hydrochloride)_SW48 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Methyl aminolevulinate (hydrochloride)_SW48 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Methyl aminolevulinate (hydrochloride)_SW48 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Ivabradine (hydrochloride)_CFPAC-1 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Ivabradine (hydrochloride)_CFPAC-1 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Ivabradine (hydrochloride)_MIA PaCa-2 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Ivabradine (hydrochloride)_MIA PaCa-2 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Rimonabant (Hydrochloride)_SK-MEL-2 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Rimonabant (Hydrochloride)_SK-MEL-2 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Topotecan (hydrochloride)_RKO Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Topotecan (hydrochloride)_RKO drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Phenylephrine (hydrochloride)_AsPC-1 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Phenylephrine (hydrochloride)_AsPC-1 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Tirabrutinib (hydrochloride)_AsPC-1 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Tirabrutinib (hydrochloride)_AsPC-1 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Dorzolamide (hydrochloride)_NCI-H661 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Dorzolamide (hydrochloride)_NCI-H661 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Ivabradine (hydrochloride)_NCI-H2122 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Ivabradine (hydrochloride)_NCI-H2122 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Procainamide (hydrochloride)_RKO Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Procainamide (hydrochloride)_RKO drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Procainamide (hydrochloride)_LOX-IMVI Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Procainamide (hydrochloride)_LOX-IMVI drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Crizotinib (hydrochloride)_CFPAC-1 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Crizotinib (hydrochloride)_CFPAC-1 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Ivabradine (hydrochloride)_RKO Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Ivabradine (hydrochloride)_RKO drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Dorzolamide (hydrochloride)_SW 1088 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Dorzolamide (hydrochloride)_SW 1088 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Fedratinib (hydrochloride hydrate)_LOX-IMVI Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Fedratinib (hydrochloride hydrate)_LOX-IMVI drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Cytarabine (hydrochloride)_NCI-H661 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Cytarabine (hydrochloride)_NCI-H661 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Crizotinib (hydrochloride)_SW 1088 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Crizotinib (hydrochloride)_SW 1088 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Levobupivacaine (hydrochloride)_NCI-H2122 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Levobupivacaine (hydrochloride)_NCI-H2122 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Tirabrutinib (hydrochloride)_LOX-IMVI Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Tirabrutinib (hydrochloride)_LOX-IMVI drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Imiquimod (hydrochloride)_CFPAC-1 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Imiquimod (hydrochloride)_CFPAC-1 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Ivabradine (hydrochloride)_A-172 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Ivabradine (hydrochloride)_A-172 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Norepinephrine (hydrochloride)_NCI-H2122 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Norepinephrine (hydrochloride)_NCI-H2122 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Dorzolamide (hydrochloride)_CFPAC-1 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Dorzolamide (hydrochloride)_CFPAC-1 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Esmolol (hydrochloride)_SK-MEL-2 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Esmolol (hydrochloride)_SK-MEL-2 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Rimonabant (Hydrochloride)_LOX-IMVI Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Rimonabant (Hydrochloride)_LOX-IMVI drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Methyl aminolevulinate (hydrochloride)_CFPAC-1 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Methyl aminolevulinate (hydrochloride)_CFPAC-1 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Ivabradine (hydrochloride)_AsPC-1 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Ivabradine (hydrochloride)_AsPC-1 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Fedratinib (hydrochloride hydrate)_LS 180 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Fedratinib (hydrochloride hydrate)_LS 180 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
(R)-Verapamil (hydrochloride)_HCT15 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the (R)-Verapamil (hydrochloride)_HCT15 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Cytarabine (hydrochloride)_CFPAC-1 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Cytarabine (hydrochloride)_CFPAC-1 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Fingolimod (hydrochloride)_SW 1271 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Fingolimod (hydrochloride)_SW 1271 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Idarubicin (hydrochloride)_NCI-H661 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Idarubicin (hydrochloride)_NCI-H661 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Loperamide (hydrochloride)_CHP-212 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Loperamide (hydrochloride)_CHP-212 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Doxorubicin (hydrochloride)_J82 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Doxorubicin (hydrochloride)_J82 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Epirubicin (hydrochloride)_HS-578T Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Epirubicin (hydrochloride)_HS-578T drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Pexidartinib (hydrochloride)_Hs 766T Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Pexidartinib (hydrochloride)_Hs 766T drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Bestatin (hydrochloride)_NCI-H2122 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Bestatin (hydrochloride)_NCI-H2122 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Doxorubicin (hydrochloride)_Hs 766T Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Doxorubicin (hydrochloride)_Hs 766T drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Almonertinib (hydrochloride)_J82 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Almonertinib (hydrochloride)_J82 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Levobupivacaine (hydrochloride)_J82 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Levobupivacaine (hydrochloride)_J82 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Epirubicin (hydrochloride)_J82 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Epirubicin (hydrochloride)_J82 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Loperamide (hydrochloride)_Hs 766T Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Loperamide (hydrochloride)_Hs 766T drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Bestatin (hydrochloride)_Hs 766T Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Bestatin (hydrochloride)_Hs 766T drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Lidocaine (hydrochloride)_hTERT-HPNE Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Lidocaine (hydrochloride)_hTERT-HPNE drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Pexidartinib (hydrochloride)_SW 1271 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Pexidartinib (hydrochloride)_SW 1271 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Cytarabine (hydrochloride)_SW 1088 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Cytarabine (hydrochloride)_SW 1088 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Crizotinib (hydrochloride)_NCI-H460 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Crizotinib (hydrochloride)_NCI-H460 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Phenylephrine (hydrochloride)_SW 1271 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Phenylephrine (hydrochloride)_SW 1271 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Ropivacaine (hydrochloride monohydrate)_H4 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Ropivacaine (hydrochloride monohydrate)_H4 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Imiquimod (hydrochloride)_SW 1271 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Imiquimod (hydrochloride)_SW 1271 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Clonidine (hydrochloride)_NCI-H661 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Clonidine (hydrochloride)_NCI-H661 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Pyridoxine (hydrochloride)_RKO Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Pyridoxine (hydrochloride)_RKO drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Levobupivacaine (hydrochloride)_SW 1271 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Levobupivacaine (hydrochloride)_SW 1271 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Bestatin (hydrochloride)_SW 1271 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Bestatin (hydrochloride)_SW 1271 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Ivabradine (hydrochloride)_H4 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Ivabradine (hydrochloride)_H4 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Crizotinib (hydrochloride)_SW 1271 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Crizotinib (hydrochloride)_SW 1271 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Ivabradine (hydrochloride)_SW 1271 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Ivabradine (hydrochloride)_SW 1271 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Fedratinib (hydrochloride hydrate)_SW 1271 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Fedratinib (hydrochloride hydrate)_SW 1271 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Tetracycline (hydrochloride)_SW 1271 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Tetracycline (hydrochloride)_SW 1271 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Idarubicin (hydrochloride)_RKO Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Idarubicin (hydrochloride)_RKO drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Esmolol (hydrochloride)_SW 1271 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Esmolol (hydrochloride)_SW 1271 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Irinotecan (hydrochloride)_SW 1271 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Irinotecan (hydrochloride)_SW 1271 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Pyridoxine (hydrochloride)_SW 1088 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Pyridoxine (hydrochloride)_SW 1088 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Cysteamine (hydrochloride)_SW 1271 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Cysteamine (hydrochloride)_SW 1271 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Norepinephrine (hydrochloride)_RKO Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Norepinephrine (hydrochloride)_RKO drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Methyl aminolevulinate (hydrochloride)_SW 1088 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Methyl aminolevulinate (hydrochloride)_SW 1088 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Norepinephrine (hydrochloride)_A-172 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Norepinephrine (hydrochloride)_A-172 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Fingolimod (hydrochloride)_SW 1088 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Fingolimod (hydrochloride)_SW 1088 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Cysteamine (hydrochloride)_C32 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Cysteamine (hydrochloride)_C32 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Ropivacaine (hydrochloride monohydrate)_SW 1271 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Ropivacaine (hydrochloride monohydrate)_SW 1271 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Tirabrutinib (hydrochloride)_RPMI-7951 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Tirabrutinib (hydrochloride)_RPMI-7951 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Clonidine (hydrochloride)_NCI-H2030 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Clonidine (hydrochloride)_NCI-H2030 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Cysteamine (hydrochloride)_NCI-H2122 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Cysteamine (hydrochloride)_NCI-H2122 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Ropivacaine (hydrochloride monohydrate)_SW1417 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Ropivacaine (hydrochloride monohydrate)_SW1417 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Norepinephrine (hydrochloride)_HS-578T Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Norepinephrine (hydrochloride)_HS-578T drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Almonertinib (hydrochloride)_A-172 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Almonertinib (hydrochloride)_A-172 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Dorzolamide (hydrochloride)_NCI-H596 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Dorzolamide (hydrochloride)_NCI-H596 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Ropivacaine (hydrochloride monohydrate)_AsPC-1 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Ropivacaine (hydrochloride monohydrate)_AsPC-1 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
(R)-Verapamil (hydrochloride)_RKO Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the (R)-Verapamil (hydrochloride)_RKO drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Esmolol (hydrochloride)_CFPAC-1 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Esmolol (hydrochloride)_CFPAC-1 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Fedratinib (hydrochloride hydrate)_NCI-H1792 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Fedratinib (hydrochloride hydrate)_NCI-H1792 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
(R)-Verapamil (hydrochloride)_LOX-IMVI Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the (R)-Verapamil (hydrochloride)_LOX-IMVI drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
(R)-Verapamil (hydrochloride)_NCI-H2347 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the (R)-Verapamil (hydrochloride)_NCI-H2347 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Norepinephrine (hydrochloride)_H4 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Norepinephrine (hydrochloride)_H4 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Bestatin (hydrochloride)_RKO Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Bestatin (hydrochloride)_RKO drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Clonidine (hydrochloride)_hTERT-HPNE Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Clonidine (hydrochloride)_hTERT-HPNE drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Esmolol (hydrochloride)_NCI-H1573 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Esmolol (hydrochloride)_NCI-H1573 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Bestatin (hydrochloride)_NCI-H460 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Bestatin (hydrochloride)_NCI-H460 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Norepinephrine (hydrochloride)_Hs 766T Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Norepinephrine (hydrochloride)_Hs 766T drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Ropivacaine (hydrochloride monohydrate)_A549 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Ropivacaine (hydrochloride monohydrate)_A549 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Almonertinib (hydrochloride)_SK-MEL-2 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Almonertinib (hydrochloride)_SK-MEL-2 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Esmolol (hydrochloride)_SW 900 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Esmolol (hydrochloride)_SW 900 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Lidocaine (hydrochloride)_NCI-H1573 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Lidocaine (hydrochloride)_NCI-H1573 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Norepinephrine (hydrochloride)_AsPC-1 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Norepinephrine (hydrochloride)_AsPC-1 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Almonertinib (hydrochloride)_SW 1088 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Almonertinib (hydrochloride)_SW 1088 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
(R)-Verapamil (hydrochloride)_NCI-H2122 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the (R)-Verapamil (hydrochloride)_NCI-H2122 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Cysteamine (hydrochloride)_NCI-H23 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Cysteamine (hydrochloride)_NCI-H23 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Clonidine (hydrochloride)_A-172 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Clonidine (hydrochloride)_A-172 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
(R)-Verapamil (hydrochloride)_NCI-H1573 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the (R)-Verapamil (hydrochloride)_NCI-H1573 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Bestatin (hydrochloride)_HOP62 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Bestatin (hydrochloride)_HOP62 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
(R)-Verapamil (hydrochloride)_C32 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the (R)-Verapamil (hydrochloride)_C32 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Norepinephrine (hydrochloride)_NCI-H2030 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Norepinephrine (hydrochloride)_NCI-H2030 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Cysteamine (hydrochloride)_LOX-IMVI Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Cysteamine (hydrochloride)_LOX-IMVI drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Cysteamine (hydrochloride)_RKO Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Cysteamine (hydrochloride)_RKO drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Phenylephrine (hydrochloride)_NCI-H596 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Phenylephrine (hydrochloride)_NCI-H596 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Clonidine (hydrochloride)_H4 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Clonidine (hydrochloride)_H4 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Cysteamine (hydrochloride)_NCI-H460 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Cysteamine (hydrochloride)_NCI-H460 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
(R)-Verapamil (hydrochloride)_J82 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the (R)-Verapamil (hydrochloride)_J82 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Fingolimod (hydrochloride)_Hs 766T Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Fingolimod (hydrochloride)_Hs 766T drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Norepinephrine (hydrochloride)_RPMI-7951 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Norepinephrine (hydrochloride)_RPMI-7951 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Clonidine (hydrochloride)_Hs 766T Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Clonidine (hydrochloride)_Hs 766T drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Lidocaine (hydrochloride)_RKO Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Lidocaine (hydrochloride)_RKO drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Lidocaine (hydrochloride)_LOX-IMVI Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Lidocaine (hydrochloride)_LOX-IMVI drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Fingolimod (hydrochloride)_NCI-H596 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Fingolimod (hydrochloride)_NCI-H596 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
(R)-Verapamil (hydrochloride)_CFPAC-1 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the (R)-Verapamil (hydrochloride)_CFPAC-1 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Esmolol (hydrochloride)_RKO Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Esmolol (hydrochloride)_RKO drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Idarubicin (hydrochloride)_SW 1271 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Idarubicin (hydrochloride)_SW 1271 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Levobupivacaine (hydrochloride)_SW 1088 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Levobupivacaine (hydrochloride)_SW 1088 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Clonidine (hydrochloride)_SK-MEL-2 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Clonidine (hydrochloride)_SK-MEL-2 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Tetracycline (hydrochloride)_RKO Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Tetracycline (hydrochloride)_RKO drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Norepinephrine (hydrochloride)_J82 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Norepinephrine (hydrochloride)_J82 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Esmolol (hydrochloride)_A-172 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Esmolol (hydrochloride)_A-172 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Irinotecan (hydrochloride)_NCI-H596 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Irinotecan (hydrochloride)_NCI-H596 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Lidocaine (hydrochloride)_H4 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Lidocaine (hydrochloride)_H4 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Clonidine (hydrochloride)_Panc 03.27 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Clonidine (hydrochloride)_Panc 03.27 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Cytarabine (hydrochloride)_NCI-H460 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Cytarabine (hydrochloride)_NCI-H460 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Lidocaine (hydrochloride)_A-172 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Lidocaine (hydrochloride)_A-172 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Tirabrutinib (hydrochloride)_RKO Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Tirabrutinib (hydrochloride)_RKO drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Lidocaine (hydrochloride)_HS-578T Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Lidocaine (hydrochloride)_HS-578T drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Idarubicin (hydrochloride)_SW 900 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Idarubicin (hydrochloride)_SW 900 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Norepinephrine (hydrochloride)_CHP-212 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Norepinephrine (hydrochloride)_CHP-212 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Doxorubicin (hydrochloride)_SK-MEL-2 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Doxorubicin (hydrochloride)_SK-MEL-2 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Tirabrutinib (hydrochloride)_NCI-H460 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Tirabrutinib (hydrochloride)_NCI-H460 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Ropivacaine (hydrochloride monohydrate)_LOX-IMVI Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Ropivacaine (hydrochloride monohydrate)_LOX-IMVI drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Ropivacaine (hydrochloride monohydrate)_RKO Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Ropivacaine (hydrochloride monohydrate)_RKO drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
(R)-Verapamil (hydrochloride)_AsPC-1 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the (R)-Verapamil (hydrochloride)_AsPC-1 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Pyridoxine (hydrochloride)_A-172 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Pyridoxine (hydrochloride)_A-172 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Ropivacaine (hydrochloride monohydrate)_NCI-H2347 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Ropivacaine (hydrochloride monohydrate)_NCI-H2347 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Norepinephrine (hydrochloride)_NCI-H1573 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Norepinephrine (hydrochloride)_NCI-H1573 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Lidocaine (hydrochloride)_SK-MEL-2 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Lidocaine (hydrochloride)_SK-MEL-2 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Norepinephrine (hydrochloride)_A498 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Norepinephrine (hydrochloride)_A498 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Fingolimod (hydrochloride)_RKO Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Fingolimod (hydrochloride)_RKO drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Ropivacaine (hydrochloride monohydrate)_NCI-H23 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Ropivacaine (hydrochloride monohydrate)_NCI-H23 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Idarubicin (hydrochloride)_HOP62 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Idarubicin (hydrochloride)_HOP62 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Lidocaine (hydrochloride)_Hs 766T Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Lidocaine (hydrochloride)_Hs 766T drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Norepinephrine (hydrochloride)_SW 900 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Norepinephrine (hydrochloride)_SW 900 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
(R)-Verapamil (hydrochloride)_SW 1271 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the (R)-Verapamil (hydrochloride)_SW 1271 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Levobupivacaine (hydrochloride)_NCI-H460 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Levobupivacaine (hydrochloride)_NCI-H460 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Ropivacaine (hydrochloride monohydrate)_CFPAC-1 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Ropivacaine (hydrochloride monohydrate)_CFPAC-1 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Loperamide (hydrochloride)_NCI-H596 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Loperamide (hydrochloride)_NCI-H596 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Tirabrutinib (hydrochloride)_SW 900 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Tirabrutinib (hydrochloride)_SW 900 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Lidocaine (hydrochloride)_AsPC-1 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Lidocaine (hydrochloride)_AsPC-1 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Idarubicin (hydrochloride)_NCI-H2347 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Idarubicin (hydrochloride)_NCI-H2347 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Methyl aminolevulinate (hydrochloride)_HOP62 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Methyl aminolevulinate (hydrochloride)_HOP62 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Topotecan (hydrochloride)_NCI-H596 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Topotecan (hydrochloride)_NCI-H596 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Idarubicin (hydrochloride)_LOX-IMVI Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Idarubicin (hydrochloride)_LOX-IMVI drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Bestatin (hydrochloride)_NCI-H596 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Bestatin (hydrochloride)_NCI-H596 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Tirabrutinib (hydrochloride)_NCI-H1792 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Tirabrutinib (hydrochloride)_NCI-H1792 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Fedratinib (hydrochloride hydrate)_A549 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Fedratinib (hydrochloride hydrate)_A549 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Cysteamine (hydrochloride)_AsPC-1 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Cysteamine (hydrochloride)_AsPC-1 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Clonidine (hydrochloride)_NCI-H1573 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Clonidine (hydrochloride)_NCI-H1573 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Ropivacaine (hydrochloride monohydrate)_NCI-H1573 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Ropivacaine (hydrochloride monohydrate)_NCI-H1573 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Clonidine (hydrochloride)_A498 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Clonidine (hydrochloride)_A498 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Ropivacaine (hydrochloride monohydrate)_C32 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Ropivacaine (hydrochloride monohydrate)_C32 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Norepinephrine (hydrochloride)_LOX-IMVI Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Norepinephrine (hydrochloride)_LOX-IMVI drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Pyridoxine (hydrochloride)_SW 1271 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Pyridoxine (hydrochloride)_SW 1271 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Clonidine (hydrochloride)_SW 900 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Clonidine (hydrochloride)_SW 900 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Cytarabine (hydrochloride)_CHP-212 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Cytarabine (hydrochloride)_CHP-212 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Pexidartinib (hydrochloride)_NCI-H2122 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Pexidartinib (hydrochloride)_NCI-H2122 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Tirabrutinib (hydrochloride)_HOP62 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Tirabrutinib (hydrochloride)_HOP62 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Norepinephrine (hydrochloride)_NCI-H2347 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Norepinephrine (hydrochloride)_NCI-H2347 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Tetracycline (hydrochloride)_NCI-H2122 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Tetracycline (hydrochloride)_NCI-H2122 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Norepinephrine (hydrochloride)_COLO 205 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Norepinephrine (hydrochloride)_COLO 205 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Bestatin (hydrochloride)_NCI-H1573 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Bestatin (hydrochloride)_NCI-H1573 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Levobupivacaine (hydrochloride)_NCI-H1573 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Levobupivacaine (hydrochloride)_NCI-H1573 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Phenylephrine (hydrochloride)_NCI-H1573 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Phenylephrine (hydrochloride)_NCI-H1573 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Norepinephrine (hydrochloride)_SW 1088 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Norepinephrine (hydrochloride)_SW 1088 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Lidocaine (hydrochloride)_SW 1088 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Lidocaine (hydrochloride)_SW 1088 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Cytarabine (hydrochloride)_HOP62 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Cytarabine (hydrochloride)_HOP62 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Cysteamine (hydrochloride)_SW 900 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Cysteamine (hydrochloride)_SW 900 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Pyridoxine (hydrochloride)_SW48 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Pyridoxine (hydrochloride)_SW48 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Cytarabine (hydrochloride)_SW480 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Cytarabine (hydrochloride)_SW480 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Lidocaine (hydrochloride)_SW48 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Lidocaine (hydrochloride)_SW48 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Idarubicin (hydrochloride)_PANC-1 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Idarubicin (hydrochloride)_PANC-1 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Norepinephrine (hydrochloride)_SW48 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Norepinephrine (hydrochloride)_SW48 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Pyridoxine (hydrochloride)_LS 180 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Pyridoxine (hydrochloride)_LS 180 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Doxorubicin (hydrochloride)_SW480 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Doxorubicin (hydrochloride)_SW480 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Lidocaine (hydrochloride)_LS 180 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Lidocaine (hydrochloride)_LS 180 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Epirubicin (hydrochloride)_AsPC-1 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Epirubicin (hydrochloride)_AsPC-1 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Clonidine (hydrochloride)_AsPC-1 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Clonidine (hydrochloride)_AsPC-1 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Idarubicin (hydrochloride)_HT-29 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Idarubicin (hydrochloride)_HT-29 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Methyl aminolevulinate (hydrochloride)_AsPC-1 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Methyl aminolevulinate (hydrochloride)_AsPC-1 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Doxorubicin (hydrochloride)_NCI-H1573 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Doxorubicin (hydrochloride)_NCI-H1573 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Clonidine (hydrochloride)_SW1417 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Clonidine (hydrochloride)_SW1417 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Epirubicin (hydrochloride)_BT-474 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Epirubicin (hydrochloride)_BT-474 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Ropivacaine (hydrochloride monohydrate)_HepG2/C3A Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Ropivacaine (hydrochloride monohydrate)_HepG2/C3A drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Norepinephrine (hydrochloride)_HEC-1-A Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Norepinephrine (hydrochloride)_HEC-1-A drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Epirubicin (hydrochloride)_SW1417 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Epirubicin (hydrochloride)_SW1417 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Crizotinib (hydrochloride)_Panc 03.27 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Crizotinib (hydrochloride)_Panc 03.27 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Pyridoxine (hydrochloride)_A498 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Pyridoxine (hydrochloride)_A498 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Epirubicin (hydrochloride)_SW 1271 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Epirubicin (hydrochloride)_SW 1271 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Norepinephrine (hydrochloride)_PANC-1 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Norepinephrine (hydrochloride)_PANC-1 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Lidocaine (hydrochloride)_NCI-H1792 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Lidocaine (hydrochloride)_NCI-H1792 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Bestatin (hydrochloride)_NCI-H2347 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Bestatin (hydrochloride)_NCI-H2347 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Cytarabine (hydrochloride)_AsPC-1 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Cytarabine (hydrochloride)_AsPC-1 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Fedratinib (hydrochloride hydrate)_A498 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Fedratinib (hydrochloride hydrate)_A498 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Cysteamine (hydrochloride)_NCI-H1792 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Cysteamine (hydrochloride)_NCI-H1792 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Almonertinib (hydrochloride)_Hs 766T Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Almonertinib (hydrochloride)_Hs 766T drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Imiquimod (hydrochloride)_Hs 766T Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Imiquimod (hydrochloride)_Hs 766T drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Levobupivacaine (hydrochloride)_HEC-1-A Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Levobupivacaine (hydrochloride)_HEC-1-A drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Lidocaine (hydrochloride)_A498 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Lidocaine (hydrochloride)_A498 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Norepinephrine (hydrochloride)_HT-29 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Norepinephrine (hydrochloride)_HT-29 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Loperamide (hydrochloride)_Panc 03.27 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Loperamide (hydrochloride)_Panc 03.27 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Cytarabine (hydrochloride)_BT-474 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Cytarabine (hydrochloride)_BT-474 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Cytarabine (hydrochloride)_SW1417 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Cytarabine (hydrochloride)_SW1417 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Phenylephrine (hydrochloride)_SW1417 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Phenylephrine (hydrochloride)_SW1417 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
(R)-Verapamil (hydrochloride)_Panc 03.27 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the (R)-Verapamil (hydrochloride)_Panc 03.27 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Imiquimod (hydrochloride)_SK-MEL-2 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Imiquimod (hydrochloride)_SK-MEL-2 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Norepinephrine (hydrochloride)_SK-MEL-2 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Norepinephrine (hydrochloride)_SK-MEL-2 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Idarubicin (hydrochloride)_H4 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Idarubicin (hydrochloride)_H4 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Lidocaine (hydrochloride)_C32 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Lidocaine (hydrochloride)_C32 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Methyl aminolevulinate (hydrochloride)_A549 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Methyl aminolevulinate (hydrochloride)_A549 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Crizotinib (hydrochloride)_NCI-H2347 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Crizotinib (hydrochloride)_NCI-H2347 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Topotecan (hydrochloride)_NCI-H2122 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Topotecan (hydrochloride)_NCI-H2122 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Almonertinib (hydrochloride)_HepG2/C3A Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Almonertinib (hydrochloride)_HepG2/C3A drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Epirubicin (hydrochloride)_A-172 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Epirubicin (hydrochloride)_A-172 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Fedratinib (hydrochloride hydrate)_Panc 03.27 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Fedratinib (hydrochloride hydrate)_Panc 03.27 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Levobupivacaine (hydrochloride)_A549 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Levobupivacaine (hydrochloride)_A549 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Cytarabine (hydrochloride)_Hs 766T Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Cytarabine (hydrochloride)_Hs 766T drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Imiquimod (hydrochloride)_AsPC-1 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Imiquimod (hydrochloride)_AsPC-1 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
(R)-Verapamil (hydrochloride)_SW48 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the (R)-Verapamil (hydrochloride)_SW48 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
(R)-Verapamil (hydrochloride)_A498 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the (R)-Verapamil (hydrochloride)_A498 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Doxorubicin (hydrochloride)_NCI-H460 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Doxorubicin (hydrochloride)_NCI-H460 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Idarubicin (hydrochloride)_LS 180 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Idarubicin (hydrochloride)_LS 180 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Norepinephrine (hydrochloride)_SW 1271 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Norepinephrine (hydrochloride)_SW 1271 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Bestatin (hydrochloride)_J82 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Bestatin (hydrochloride)_J82 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Phenylephrine (hydrochloride)_SK-MEL-2 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Phenylephrine (hydrochloride)_SK-MEL-2 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Doxorubicin (hydrochloride)_RKO Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Doxorubicin (hydrochloride)_RKO drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Methyl aminolevulinate (hydrochloride)_Hs 766T Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Methyl aminolevulinate (hydrochloride)_Hs 766T drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Ropivacaine (hydrochloride monohydrate)_SK-MEL-2 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Ropivacaine (hydrochloride monohydrate)_SK-MEL-2 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Rimonabant (Hydrochloride)_AsPC-1 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Rimonabant (Hydrochloride)_AsPC-1 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Clonidine (hydrochloride)_HT-29 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Clonidine (hydrochloride)_HT-29 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Irinotecan (hydrochloride)_Panc 03.27 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Irinotecan (hydrochloride)_Panc 03.27 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Bestatin (hydrochloride)_A498 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Bestatin (hydrochloride)_A498 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Doxorubicin (hydrochloride)_Panc 03.27 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Doxorubicin (hydrochloride)_Panc 03.27 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Levobupivacaine (hydrochloride)_AsPC-1 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Levobupivacaine (hydrochloride)_AsPC-1 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Cytarabine (hydrochloride)_HEC-1-A Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Cytarabine (hydrochloride)_HEC-1-A drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Norepinephrine (hydrochloride)_A549 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Norepinephrine (hydrochloride)_A549 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Imiquimod (hydrochloride)_A549 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Imiquimod (hydrochloride)_A549 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Tirabrutinib (hydrochloride)_HEC-1-A Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Tirabrutinib (hydrochloride)_HEC-1-A drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Cytarabine (hydrochloride)_PANC-1 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Cytarabine (hydrochloride)_PANC-1 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Cysteamine (hydrochloride)_Panc 03.27 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Cysteamine (hydrochloride)_Panc 03.27 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Rimonabant (Hydrochloride)_NCI-H1573 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Rimonabant (Hydrochloride)_NCI-H1573 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Crizotinib (hydrochloride)_AsPC-1 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Crizotinib (hydrochloride)_AsPC-1 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Cysteamine (hydrochloride)_HT-29 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Cysteamine (hydrochloride)_HT-29 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Rimonabant (Hydrochloride)_C32 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Rimonabant (Hydrochloride)_C32 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Doxorubicin (hydrochloride)_HT-29 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Doxorubicin (hydrochloride)_HT-29 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Loperamide (hydrochloride)_A549 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Loperamide (hydrochloride)_A549 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Ropivacaine (hydrochloride monohydrate)_Panc 03.27 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Ropivacaine (hydrochloride monohydrate)_Panc 03.27 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Bestatin (hydrochloride)_SW1417 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Bestatin (hydrochloride)_SW1417 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Epirubicin (hydrochloride)_Panc 03.27 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Epirubicin (hydrochloride)_Panc 03.27 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Irinotecan (hydrochloride)_Hs 766T Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Irinotecan (hydrochloride)_Hs 766T drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Topotecan (hydrochloride)_A549 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Topotecan (hydrochloride)_A549 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Cytarabine (hydrochloride)_NCI-H2347 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Cytarabine (hydrochloride)_NCI-H2347 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Bestatin (hydrochloride)_AsPC-1 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Bestatin (hydrochloride)_AsPC-1 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Topotecan (hydrochloride)_AsPC-1 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Topotecan (hydrochloride)_AsPC-1 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Doxorubicin (hydrochloride)_A-172 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Doxorubicin (hydrochloride)_A-172 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Imiquimod (hydrochloride)_NCI-H1573 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Imiquimod (hydrochloride)_NCI-H1573 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Rimonabant (Hydrochloride)_J82 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Rimonabant (Hydrochloride)_J82 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Lidocaine (hydrochloride)_NCI-H596 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Lidocaine (hydrochloride)_NCI-H596 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Fedratinib (hydrochloride hydrate)_SK-MEL-2 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Fedratinib (hydrochloride hydrate)_SK-MEL-2 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Norepinephrine (hydrochloride)_C32 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Norepinephrine (hydrochloride)_C32 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
(R)-Verapamil (hydrochloride)_NCI-H2030 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the (R)-Verapamil (hydrochloride)_NCI-H2030 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Irinotecan (hydrochloride)_HEC-1-A Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Irinotecan (hydrochloride)_HEC-1-A drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Idarubicin (hydrochloride)_NCI-H1792 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Idarubicin (hydrochloride)_NCI-H1792 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Imiquimod (hydrochloride)_NCI-H2122 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Imiquimod (hydrochloride)_NCI-H2122 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
(R)-Verapamil (hydrochloride)_SW1417 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the (R)-Verapamil (hydrochloride)_SW1417 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Phenylephrine (hydrochloride)_Panc 03.27 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Phenylephrine (hydrochloride)_Panc 03.27 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Epirubicin (hydrochloride)_NCI-H460 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Epirubicin (hydrochloride)_NCI-H460 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Tirabrutinib (hydrochloride)_Panc 03.27 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Tirabrutinib (hydrochloride)_Panc 03.27 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Clonidine (hydrochloride)_NCI-H2347 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Clonidine (hydrochloride)_NCI-H2347 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Doxorubicin (hydrochloride)_H4 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Doxorubicin (hydrochloride)_H4 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Cysteamine (hydrochloride)_HEC-1-A Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Cysteamine (hydrochloride)_HEC-1-A drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Tirabrutinib (hydrochloride)_C32 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Tirabrutinib (hydrochloride)_C32 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Clonidine (hydrochloride)_J82 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Clonidine (hydrochloride)_J82 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Lidocaine (hydrochloride)_SW1417 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Lidocaine (hydrochloride)_SW1417 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Cytarabine (hydrochloride)_NCI-H1573 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Cytarabine (hydrochloride)_NCI-H1573 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Lidocaine (hydrochloride)_SW 1271 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Lidocaine (hydrochloride)_SW 1271 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Topotecan (hydrochloride)_Hs 766T Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Topotecan (hydrochloride)_Hs 766T drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Cytarabine (hydrochloride)_C32 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Cytarabine (hydrochloride)_C32 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
(R)-Verapamil (hydrochloride)_HT-29 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the (R)-Verapamil (hydrochloride)_HT-29 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Clonidine (hydrochloride)_NCI-H1792 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Clonidine (hydrochloride)_NCI-H1792 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Cytarabine (hydrochloride)_A498 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Cytarabine (hydrochloride)_A498 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Norepinephrine (hydrochloride)_Panc 03.27 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Norepinephrine (hydrochloride)_Panc 03.27 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Idarubicin (hydrochloride)_NCI-H460 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Idarubicin (hydrochloride)_NCI-H460 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Epirubicin (hydrochloride)_HOP62 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Epirubicin (hydrochloride)_HOP62 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
(R)-Verapamil (hydrochloride)_SK-MEL-2 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the (R)-Verapamil (hydrochloride)_SK-MEL-2 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Imiquimod (hydrochloride)_Panc 03.27 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Imiquimod (hydrochloride)_Panc 03.27 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Lidocaine (hydrochloride)_HepG2/C3A Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Lidocaine (hydrochloride)_HepG2/C3A drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Tirabrutinib (hydrochloride)_A498 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Tirabrutinib (hydrochloride)_A498 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Methyl aminolevulinate (hydrochloride)_LoVo Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Methyl aminolevulinate (hydrochloride)_LoVo drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Doxorubicin (hydrochloride)_AsPC-1 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Doxorubicin (hydrochloride)_AsPC-1 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Cysteamine (hydrochloride)_HepG2/C3A Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Cysteamine (hydrochloride)_HepG2/C3A drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Fingolimod (hydrochloride)_NCI-H1573 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Fingolimod (hydrochloride)_NCI-H1573 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Bestatin (hydrochloride)_SK-MEL-2 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Bestatin (hydrochloride)_SK-MEL-2 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Epirubicin (hydrochloride)_C32 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Epirubicin (hydrochloride)_C32 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Clonidine (hydrochloride)_C32 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Clonidine (hydrochloride)_C32 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Ropivacaine (hydrochloride monohydrate)_A498 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Ropivacaine (hydrochloride monohydrate)_A498 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Epirubicin (hydrochloride)_NCI-H1573 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Epirubicin (hydrochloride)_NCI-H1573 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Ropivacaine (hydrochloride monohydrate)_AN3 CA Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Ropivacaine (hydrochloride monohydrate)_AN3 CA drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Idarubicin (hydrochloride)_Panc 03.27 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Idarubicin (hydrochloride)_Panc 03.27 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Doxorubicin (hydrochloride)_BT-474 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Doxorubicin (hydrochloride)_BT-474 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Doxorubicin (hydrochloride)_SW1417 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Doxorubicin (hydrochloride)_SW1417 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
(R)-Verapamil (hydrochloride)_HEC-1-A Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the (R)-Verapamil (hydrochloride)_HEC-1-A drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Fingolimod (hydrochloride)_A498 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Fingolimod (hydrochloride)_A498 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Procainamide (hydrochloride)_BT-474 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Procainamide (hydrochloride)_BT-474 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Methyl aminolevulinate (hydrochloride)_A498 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Methyl aminolevulinate (hydrochloride)_A498 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Levobupivacaine (hydrochloride)_A-172 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Levobupivacaine (hydrochloride)_A-172 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
(R)-Verapamil (hydrochloride)_A549 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the (R)-Verapamil (hydrochloride)_A549 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Esmolol (hydrochloride)_HepG2/C3A Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Esmolol (hydrochloride)_HepG2/C3A drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Pyridoxine (hydrochloride)_HepG2/C3A Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Pyridoxine (hydrochloride)_HepG2/C3A drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Tetracycline (hydrochloride)_A549 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Tetracycline (hydrochloride)_A549 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Bestatin (hydrochloride)_KATO III Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Bestatin (hydrochloride)_KATO III drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Levobupivacaine (hydrochloride)_BT-474 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Levobupivacaine (hydrochloride)_BT-474 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Bestatin (hydrochloride)_BT-474 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Bestatin (hydrochloride)_BT-474 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Lidocaine (hydrochloride)_BT-474 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Lidocaine (hydrochloride)_BT-474 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Tirabrutinib (hydrochloride)_C-33 A Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Tirabrutinib (hydrochloride)_C-33 A drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Esmolol (hydrochloride)_BT-474 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Esmolol (hydrochloride)_BT-474 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Phenylephrine (hydrochloride)_C-33 A Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Phenylephrine (hydrochloride)_C-33 A drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Ropivacaine (hydrochloride monohydrate)_HCT15 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Ropivacaine (hydrochloride monohydrate)_HCT15 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Epirubicin (hydrochloride)_SW 900 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Epirubicin (hydrochloride)_SW 900 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Phenylephrine (hydrochloride)_RPMI-7951 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Phenylephrine (hydrochloride)_RPMI-7951 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Dorzolamide (hydrochloride)_Hs 766T Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Dorzolamide (hydrochloride)_Hs 766T drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Procainamide (hydrochloride)_AN3 CA Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Procainamide (hydrochloride)_AN3 CA drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Methyl aminolevulinate (hydrochloride)_COLO 205 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Methyl aminolevulinate (hydrochloride)_COLO 205 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Levobupivacaine (hydrochloride)_NCI-H596 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Levobupivacaine (hydrochloride)_NCI-H596 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Irinotecan (hydrochloride)_NCI-H2122 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Irinotecan (hydrochloride)_NCI-H2122 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Procainamide (hydrochloride)_A498 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Procainamide (hydrochloride)_A498 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Epirubicin (hydrochloride)_RPMI-7951 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Epirubicin (hydrochloride)_RPMI-7951 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Tetracycline (hydrochloride)_NCI-H1573 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Tetracycline (hydrochloride)_NCI-H1573 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Fedratinib (hydrochloride hydrate)_SW 900 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Fedratinib (hydrochloride hydrate)_SW 900 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Methyl aminolevulinate (hydrochloride)_LS 180 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Methyl aminolevulinate (hydrochloride)_LS 180 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Dorzolamide (hydrochloride)_HCT15 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Dorzolamide (hydrochloride)_HCT15 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Epirubicin (hydrochloride)_LS 180 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Epirubicin (hydrochloride)_LS 180 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Procainamide (hydrochloride)_LoVo Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Procainamide (hydrochloride)_LoVo drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Procainamide (hydrochloride)_MIA PaCa-2 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Procainamide (hydrochloride)_MIA PaCa-2 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Tirabrutinib (hydrochloride)_Hs 766T Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Tirabrutinib (hydrochloride)_Hs 766T drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Loperamide (hydrochloride)_SW 900 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Loperamide (hydrochloride)_SW 900 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Loperamide (hydrochloride)_A498 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Loperamide (hydrochloride)_A498 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Phenylephrine (hydrochloride)_Hs 766T Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Phenylephrine (hydrochloride)_Hs 766T drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Dorzolamide (hydrochloride)_hTERT-HPNE Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Dorzolamide (hydrochloride)_hTERT-HPNE drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Levobupivacaine (hydrochloride)_LS 180 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Levobupivacaine (hydrochloride)_LS 180 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Fingolimod (hydrochloride)_HCT15 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Fingolimod (hydrochloride)_HCT15 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Epirubicin (hydrochloride)_HCT15 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Epirubicin (hydrochloride)_HCT15 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Fingolimod (hydrochloride)_HT-29 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Fingolimod (hydrochloride)_HT-29 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Crizotinib (hydrochloride)_NCI-H2122 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Crizotinib (hydrochloride)_NCI-H2122 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Crizotinib (hydrochloride)_SW48 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Crizotinib (hydrochloride)_SW48 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Topotecan (hydrochloride)_MIA PaCa-2 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Topotecan (hydrochloride)_MIA PaCa-2 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Phenylephrine (hydrochloride)_H4 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Phenylephrine (hydrochloride)_H4 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Loperamide (hydrochloride)_J82 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Loperamide (hydrochloride)_J82 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Procainamide (hydrochloride)_HT-29 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Procainamide (hydrochloride)_HT-29 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Levobupivacaine (hydrochloride)_SW 900 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Levobupivacaine (hydrochloride)_SW 900 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Fedratinib (hydrochloride hydrate)_H4 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Fedratinib (hydrochloride hydrate)_H4 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Dorzolamide (hydrochloride)_SW 900 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Dorzolamide (hydrochloride)_SW 900 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Tirabrutinib (hydrochloride)_NCI-H2347 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Tirabrutinib (hydrochloride)_NCI-H2347 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Fingolimod (hydrochloride)_NCI-H23 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Fingolimod (hydrochloride)_NCI-H23 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Dorzolamide (hydrochloride)_NCI-H1792 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Dorzolamide (hydrochloride)_NCI-H1792 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Rimonabant (Hydrochloride)_KATO III Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Rimonabant (Hydrochloride)_KATO III drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Dorzolamide (hydrochloride)_KATO III Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Dorzolamide (hydrochloride)_KATO III drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Levobupivacaine (hydrochloride)_KATO III Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Levobupivacaine (hydrochloride)_KATO III drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Methyl aminolevulinate (hydrochloride)_NCI-H460 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Methyl aminolevulinate (hydrochloride)_NCI-H460 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Dorzolamide (hydrochloride)_NCI-H23 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Dorzolamide (hydrochloride)_NCI-H23 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Levobupivacaine (hydrochloride)_RKO Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Levobupivacaine (hydrochloride)_RKO drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Methyl aminolevulinate (hydrochloride)_KATO III Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Methyl aminolevulinate (hydrochloride)_KATO III drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Levobupivacaine (hydrochloride)_NCI-H23 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Levobupivacaine (hydrochloride)_NCI-H23 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Fingolimod (hydrochloride)_LoVo Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Fingolimod (hydrochloride)_LoVo drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Loperamide (hydrochloride)_HCT15 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Loperamide (hydrochloride)_HCT15 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Procainamide (hydrochloride)_SW 1088 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Procainamide (hydrochloride)_SW 1088 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Procainamide (hydrochloride)_COLO 205 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Procainamide (hydrochloride)_COLO 205 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Methyl aminolevulinate (hydrochloride)_SW 900 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Methyl aminolevulinate (hydrochloride)_SW 900 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Fingolimod (hydrochloride)_SW 900 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Fingolimod (hydrochloride)_SW 900 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Dorzolamide (hydrochloride)_Panc 03.27 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Dorzolamide (hydrochloride)_Panc 03.27 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Loperamide (hydrochloride)_A-172 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Loperamide (hydrochloride)_A-172 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Topotecan (hydrochloride)_HCT15 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Topotecan (hydrochloride)_HCT15 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Clonidine (hydrochloride)_SW 1088 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Clonidine (hydrochloride)_SW 1088 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Pexidartinib (hydrochloride)_A549 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Pexidartinib (hydrochloride)_A549 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Irinotecan (hydrochloride)_NCI-H1573 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Irinotecan (hydrochloride)_NCI-H1573 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Crizotinib (hydrochloride)_NCI-H1573 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Crizotinib (hydrochloride)_NCI-H1573 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Crizotinib (hydrochloride)_SHP-77 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Crizotinib (hydrochloride)_SHP-77 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Crizotinib (hydrochloride)_hTERT-HPNE Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Crizotinib (hydrochloride)_hTERT-HPNE drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Crizotinib (hydrochloride)_HCT15 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Crizotinib (hydrochloride)_HCT15 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Tirabrutinib (hydrochloride)_SW 1271 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Tirabrutinib (hydrochloride)_SW 1271 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Crizotinib (hydrochloride)_CHP-212 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Crizotinib (hydrochloride)_CHP-212 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Crizotinib (hydrochloride)_A-427 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Crizotinib (hydrochloride)_A-427 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Crizotinib (hydrochloride)_C-33 A Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Crizotinib (hydrochloride)_C-33 A drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Crizotinib (hydrochloride)_BT-474 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Crizotinib (hydrochloride)_BT-474 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Crizotinib (hydrochloride)_A549 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Crizotinib (hydrochloride)_A549 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Crizotinib (hydrochloride)_HS-578T Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Crizotinib (hydrochloride)_HS-578T drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Idarubicin (hydrochloride)_AN3 CA Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Idarubicin (hydrochloride)_AN3 CA drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Crizotinib (hydrochloride)_KATO III Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Crizotinib (hydrochloride)_KATO III drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Imiquimod (hydrochloride)_HS-578T Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Imiquimod (hydrochloride)_HS-578T drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Procainamide (hydrochloride)_C32 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Procainamide (hydrochloride)_C32 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Pexidartinib (hydrochloride)_SW1417 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Pexidartinib (hydrochloride)_SW1417 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Methyl aminolevulinate (hydrochloride)_BT-474 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Methyl aminolevulinate (hydrochloride)_BT-474 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Methyl aminolevulinate (hydrochloride)_SW1417 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Methyl aminolevulinate (hydrochloride)_SW1417 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Irinotecan (hydrochloride)_CHP-212 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Irinotecan (hydrochloride)_CHP-212 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Rimonabant (Hydrochloride)_HS-578T Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Rimonabant (Hydrochloride)_HS-578T drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Tetracycline (hydrochloride)_AN3 CA Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Tetracycline (hydrochloride)_AN3 CA drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Ivabradine (hydrochloride)_AN3 CA Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Ivabradine (hydrochloride)_AN3 CA drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Rimonabant (Hydrochloride)_NCI-H661 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Rimonabant (Hydrochloride)_NCI-H661 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Ivabradine (hydrochloride)_C32 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Ivabradine (hydrochloride)_C32 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Fedratinib (hydrochloride hydrate)_C32 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Fedratinib (hydrochloride hydrate)_C32 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Bestatin (hydrochloride)_CFPAC-1 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Bestatin (hydrochloride)_CFPAC-1 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Topotecan (hydrochloride)_C32 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Topotecan (hydrochloride)_C32 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Methyl aminolevulinate (hydrochloride)_NCI-H661 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Methyl aminolevulinate (hydrochloride)_NCI-H661 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Fingolimod (hydrochloride)_NCI-H661 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Fingolimod (hydrochloride)_NCI-H661 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Loperamide (hydrochloride)_C32 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Loperamide (hydrochloride)_C32 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Epirubicin (hydrochloride)_NCI-H661 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Epirubicin (hydrochloride)_NCI-H661 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Tirabrutinib (hydrochloride)_HS-578T Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Tirabrutinib (hydrochloride)_HS-578T drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Bestatin (hydrochloride)_C-33 A Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Bestatin (hydrochloride)_C-33 A drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Crizotinib (hydrochloride)_AN3 CA Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Crizotinib (hydrochloride)_AN3 CA drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Crizotinib (hydrochloride)_C32 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Crizotinib (hydrochloride)_C32 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Methyl aminolevulinate (hydrochloride)_NCI-H596 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Methyl aminolevulinate (hydrochloride)_NCI-H596 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Bestatin (hydrochloride)_AN3 CA Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Bestatin (hydrochloride)_AN3 CA drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Rimonabant (Hydrochloride)_BT-474 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Rimonabant (Hydrochloride)_BT-474 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Dorzolamide (hydrochloride)_C32 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Dorzolamide (hydrochloride)_C32 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Rimonabant (Hydrochloride)_AN3 CA Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Rimonabant (Hydrochloride)_AN3 CA drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Idarubicin (hydrochloride)_NCI-H2122 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Idarubicin (hydrochloride)_NCI-H2122 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Fedratinib (hydrochloride hydrate)_NCI-H661 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Fedratinib (hydrochloride hydrate)_NCI-H661 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Imiquimod (hydrochloride)_CHP-212 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Imiquimod (hydrochloride)_CHP-212 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Phenylephrine (hydrochloride)_NCI-H2347 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Phenylephrine (hydrochloride)_NCI-H2347 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
(R)-Verapamil (hydrochloride)_LS 180 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the (R)-Verapamil (hydrochloride)_LS 180 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Procainamide (hydrochloride)_HS-578T Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Procainamide (hydrochloride)_HS-578T drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Almonertinib (hydrochloride)_AN3 CA Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Almonertinib (hydrochloride)_AN3 CA drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Irinotecan (hydrochloride)_NCI-H661 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Irinotecan (hydrochloride)_NCI-H661 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Fedratinib (hydrochloride hydrate)_NCI-H596 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Fedratinib (hydrochloride hydrate)_NCI-H596 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Almonertinib (hydrochloride)_NCI-H2122 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Almonertinib (hydrochloride)_NCI-H2122 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Rimonabant (Hydrochloride)_CHP-212 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Rimonabant (Hydrochloride)_CHP-212 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Doxorubicin (hydrochloride)_NCI-H661 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Doxorubicin (hydrochloride)_NCI-H661 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Bestatin (hydrochloride)_NCI-H661 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Bestatin (hydrochloride)_NCI-H661 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Cytarabine (hydrochloride)_AN3 CA Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Cytarabine (hydrochloride)_AN3 CA drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Procainamide (hydrochloride)_RPMI-7951 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Procainamide (hydrochloride)_RPMI-7951 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Phenylephrine (hydrochloride)_AN3 CA Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Phenylephrine (hydrochloride)_AN3 CA drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Phenylephrine (hydrochloride)_SHP-77 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Phenylephrine (hydrochloride)_SHP-77 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Methyl aminolevulinate (hydrochloride)_CHP-212 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Methyl aminolevulinate (hydrochloride)_CHP-212 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Fingolimod (hydrochloride)_CHP-212 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Fingolimod (hydrochloride)_CHP-212 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Crizotinib (hydrochloride)_NCI-H661 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Crizotinib (hydrochloride)_NCI-H661 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Cytarabine (hydrochloride)_KATO III Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Cytarabine (hydrochloride)_KATO III drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Doxorubicin (hydrochloride)_SW 1088 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Doxorubicin (hydrochloride)_SW 1088 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Methyl aminolevulinate (hydrochloride)_NCI-H2122 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Methyl aminolevulinate (hydrochloride)_NCI-H2122 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Phenylephrine (hydrochloride)_HOP62 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Phenylephrine (hydrochloride)_HOP62 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Loperamide (hydrochloride)_HS-578T Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Loperamide (hydrochloride)_HS-578T drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Phenylephrine (hydrochloride)_CHP-212 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Phenylephrine (hydrochloride)_CHP-212 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Tirabrutinib (hydrochloride)_HepG2/C3A Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Tirabrutinib (hydrochloride)_HepG2/C3A drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Loperamide (hydrochloride)_HepG2/C3A Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Loperamide (hydrochloride)_HepG2/C3A drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
(R)-Verapamil (hydrochloride)_COLO 205 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the (R)-Verapamil (hydrochloride)_COLO 205 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Clonidine (hydrochloride)_KATO III Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Clonidine (hydrochloride)_KATO III drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Fedratinib (hydrochloride hydrate)_KATO III Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Fedratinib (hydrochloride hydrate)_KATO III drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Ivabradine (hydrochloride)_KATO III Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Ivabradine (hydrochloride)_KATO III drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Phenylephrine (hydrochloride)_BT-474 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Phenylephrine (hydrochloride)_BT-474 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Imiquimod (hydrochloride)_BT-474 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Imiquimod (hydrochloride)_BT-474 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Topotecan (hydrochloride)_KATO III Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Topotecan (hydrochloride)_KATO III drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Loperamide (hydrochloride)_BT-474 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Loperamide (hydrochloride)_BT-474 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Fedratinib (hydrochloride hydrate)_BT-474 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Fedratinib (hydrochloride hydrate)_BT-474 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Ivabradine (hydrochloride)_BT-474 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Ivabradine (hydrochloride)_BT-474 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Tetracycline (hydrochloride)_BT-474 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Tetracycline (hydrochloride)_BT-474 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Pexidartinib (hydrochloride)_SK-MEL-2 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Pexidartinib (hydrochloride)_SK-MEL-2 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Fedratinib (hydrochloride hydrate)_MIA PaCa-2 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Fedratinib (hydrochloride hydrate)_MIA PaCa-2 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Esmolol (hydrochloride)_J82 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Esmolol (hydrochloride)_J82 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Cysteamine (hydrochloride)_AN3 CA Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Cysteamine (hydrochloride)_AN3 CA drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Cysteamine (hydrochloride)_NCI-H1573 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Cysteamine (hydrochloride)_NCI-H1573 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Fedratinib (hydrochloride hydrate)_LoVo Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Fedratinib (hydrochloride hydrate)_LoVo drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Fedratinib (hydrochloride hydrate)_HOP62 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Fedratinib (hydrochloride hydrate)_HOP62 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Lidocaine (hydrochloride)_HOP62 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Lidocaine (hydrochloride)_HOP62 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Ropivacaine (hydrochloride monohydrate)_BT-474 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Ropivacaine (hydrochloride monohydrate)_BT-474 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Fedratinib (hydrochloride hydrate)_CFPAC-1 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Fedratinib (hydrochloride hydrate)_CFPAC-1 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Fedratinib (hydrochloride hydrate)_CHP-212 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Fedratinib (hydrochloride hydrate)_CHP-212 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Esmolol (hydrochloride)_NCI-H1792 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Esmolol (hydrochloride)_NCI-H1792 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Cysteamine (hydrochloride)_A-427 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Cysteamine (hydrochloride)_A-427 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Lidocaine (hydrochloride)_CHP-212 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Lidocaine (hydrochloride)_CHP-212 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Esmolol (hydrochloride)_MIA PaCa-2 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Esmolol (hydrochloride)_MIA PaCa-2 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Esmolol (hydrochloride)_LoVo Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Esmolol (hydrochloride)_LoVo drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Pexidartinib (hydrochloride)_NCI-H2030 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Pexidartinib (hydrochloride)_NCI-H2030 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Irinotecan (hydrochloride)_A-427 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Irinotecan (hydrochloride)_A-427 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Cysteamine (hydrochloride)_A498 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Cysteamine (hydrochloride)_A498 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Cysteamine (hydrochloride)_SW48 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Cysteamine (hydrochloride)_SW48 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Cytarabine (hydrochloride)_LS 180 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Cytarabine (hydrochloride)_LS 180 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Esmolol (hydrochloride)_A-427 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Esmolol (hydrochloride)_A-427 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Fedratinib (hydrochloride hydrate)_SW48 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Fedratinib (hydrochloride hydrate)_SW48 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Ropivacaine (hydrochloride monohydrate)_SW480 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Ropivacaine (hydrochloride monohydrate)_SW480 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Lidocaine (hydrochloride)_SHP-77 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Lidocaine (hydrochloride)_SHP-77 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Ropivacaine (hydrochloride monohydrate)_LS 180 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Ropivacaine (hydrochloride monohydrate)_LS 180 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Pexidartinib (hydrochloride)_SW480 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Pexidartinib (hydrochloride)_SW480 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Pyridoxine (hydrochloride)_J82 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Pyridoxine (hydrochloride)_J82 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Fedratinib (hydrochloride hydrate)_SHP-77 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Fedratinib (hydrochloride hydrate)_SHP-77 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Irinotecan (hydrochloride)_HOP62 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Irinotecan (hydrochloride)_HOP62 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Esmolol (hydrochloride)_AN3 CA Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Esmolol (hydrochloride)_AN3 CA drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Fedratinib (hydrochloride hydrate)_C-33 A Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Fedratinib (hydrochloride hydrate)_C-33 A drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Cytarabine (hydrochloride)_NCI-H2030 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Cytarabine (hydrochloride)_NCI-H2030 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Fedratinib (hydrochloride hydrate)_A-427 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Fedratinib (hydrochloride hydrate)_A-427 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Esmolol (hydrochloride)_SW48 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Esmolol (hydrochloride)_SW48 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Almonertinib (hydrochloride)_NCI-H596 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Almonertinib (hydrochloride)_NCI-H596 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Cysteamine (hydrochloride)_CHP-212 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Cysteamine (hydrochloride)_CHP-212 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Lidocaine (hydrochloride)_A-427 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Lidocaine (hydrochloride)_A-427 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Pyridoxine (hydrochloride)_HOP62 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Pyridoxine (hydrochloride)_HOP62 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Procainamide (hydrochloride)_CFPAC-1 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Procainamide (hydrochloride)_CFPAC-1 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Cysteamine (hydrochloride)_LoVo Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Cysteamine (hydrochloride)_LoVo drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Clonidine (hydrochloride)_LS 180 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Clonidine (hydrochloride)_LS 180 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Irinotecan (hydrochloride)_KATO III Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Irinotecan (hydrochloride)_KATO III drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Cysteamine (hydrochloride)_MIA PaCa-2 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Cysteamine (hydrochloride)_MIA PaCa-2 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Fedratinib (hydrochloride hydrate)_NCI-H1573 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Fedratinib (hydrochloride hydrate)_NCI-H1573 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Esmolol (hydrochloride)_C-33 A Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Esmolol (hydrochloride)_C-33 A drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Lidocaine (hydrochloride)_AN3 CA Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Lidocaine (hydrochloride)_AN3 CA drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Irinotecan (hydrochloride)_LOX-IMVI Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Irinotecan (hydrochloride)_LOX-IMVI drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Pexidartinib (hydrochloride)_PANC-1 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Pexidartinib (hydrochloride)_PANC-1 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Topotecan (hydrochloride)_A-427 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Topotecan (hydrochloride)_A-427 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Irinotecan (hydrochloride)_RKO Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Irinotecan (hydrochloride)_RKO drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Irinotecan (hydrochloride)_NCI-H2347 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Irinotecan (hydrochloride)_NCI-H2347 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Irinotecan (hydrochloride)_NCI-H460 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Irinotecan (hydrochloride)_NCI-H460 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Almonertinib (hydrochloride)_COLO 205 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Almonertinib (hydrochloride)_COLO 205 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Pexidartinib (hydrochloride)_HS-578T Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Pexidartinib (hydrochloride)_HS-578T drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Dorzolamide (hydrochloride)_LS 180 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Dorzolamide (hydrochloride)_LS 180 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Almonertinib (hydrochloride)_SW 1271 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Almonertinib (hydrochloride)_SW 1271 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Dorzolamide (hydrochloride)_A549 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Dorzolamide (hydrochloride)_A549 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Fedratinib (hydrochloride hydrate)_NCI-H460 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Fedratinib (hydrochloride hydrate)_NCI-H460 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.

Harmonizome 3.0

(R)-Verapamil (hydrochloride)_SNU-1 Gene Set

Lidocaine (hydrochloride)_SNU-423 Gene Set

Ivabradine (hydrochloride)_SNU-423 Gene Set

Esmolol (hydrochloride)_SNU-423 Gene Set

Doxorubicin (hydrochloride)_SNU-423 Gene Set

Pyridoxine (hydrochloride)_SNU-423 Gene Set

Cysteamine (hydrochloride)_SNU-423 Gene Set

(R)-Verapamil (hydrochloride)_SNU-423 Gene Set

Dorzolamide (hydrochloride)_SNU-423 Gene Set

Ropivacaine (hydrochloride monohydrate)_SNU-423 Gene Set

Pexidartinib (hydrochloride)_SNU-423 Gene Set

Topotecan (hydrochloride)_SNU-423 Gene Set

Doxorubicin (hydrochloride)_SNU-1 Gene Set

Phenylephrine (hydrochloride)_SNU-1 Gene Set

Fingolimod (hydrochloride)_SNU-423 Gene Set

Procainamide (hydrochloride)_SNU-1 Gene Set

Clonidine (hydrochloride)_SNU-1 Gene Set

Tetracycline (hydrochloride)_SNU-423 Gene Set

Norepinephrine (hydrochloride)_SNU-423 Gene Set

Irinotecan (hydrochloride)_SNU-423 Gene Set

Fingolimod (hydrochloride)_SNU-1 Gene Set

Epirubicin (hydrochloride)_SNU-423 Gene Set

Cytarabine (hydrochloride)_SNU-423 Gene Set

Phenylephrine (hydrochloride)_SNU-423 Gene Set

Methyl aminolevulinate (hydrochloride)_SNU-423 Gene Set

Fedratinib (hydrochloride hydrate)_SNU-423 Gene Set

Topotecan (hydrochloride)_SNU-1 Gene Set

Ivabradine (hydrochloride)_SNU-1 Gene Set

Fedratinib (hydrochloride hydrate)_SNU-1 Gene Set

Cysteamine (hydrochloride)_SNU-1 Gene Set

Cytarabine (hydrochloride)_SNU-1 Gene Set

Rimonabant (Hydrochloride)_SNU-423 Gene Set

Bestatin (hydrochloride)_SNU-1 Gene Set

Loperamide (hydrochloride)_SNU-1 Gene Set

Lidocaine (hydrochloride)_SNU-1 Gene Set

Esmolol (hydrochloride)_SNU-1 Gene Set

Tetracycline (hydrochloride)_SNU-1 Gene Set

Ropivacaine (hydrochloride monohydrate)_SNU-1 Gene Set

Pexidartinib (hydrochloride)_SNU-1 Gene Set

Methyl aminolevulinate (hydrochloride)_SNU-1 Gene Set

Epirubicin (hydrochloride)_SNU-1 Gene Set

Tirabrutinib (hydrochloride)_SNU-1 Gene Set

Almonertinib (hydrochloride)_SNU-1 Gene Set

Levobupivacaine (hydrochloride)_SNU-1 Gene Set

Rimonabant (Hydrochloride)_SNU-1 Gene Set

Procainamide (hydrochloride)_SNU-423 Gene Set

Imiquimod (hydrochloride)_SNU-1 Gene Set

Idarubicin (hydrochloride)_SNU-1 Gene Set

Crizotinib (hydrochloride)_SNU-423 Gene Set

Loperamide (hydrochloride)_SNU-423 Gene Set

Clonidine (hydrochloride)_SNU-423 Gene Set

Tirabrutinib (hydrochloride)_SNU-423 Gene Set

Idarubicin (hydrochloride)_SNU-423 Gene Set

Bestatin (hydrochloride)_SNU-423 Gene Set

Dorzolamide (hydrochloride)_SNU-1 Gene Set

Pyridoxine (hydrochloride)_SNU-1 Gene Set

Norepinephrine (hydrochloride)_SNU-1 Gene Set

Imiquimod (hydrochloride)_SNU-423 Gene Set

Crizotinib (hydrochloride)_SNU-1 Gene Set

Irinotecan (hydrochloride)_SNU-1 Gene Set

Levobupivacaine (hydrochloride)_SNU-423 Gene Set

Almonertinib (hydrochloride)_SNU-423 Gene Set

Lactate (calcium)_SNU-423 Gene Set

Lumateperone (tosylate)_SNU-1 Gene Set

Fluvoxamine (maleate)_SNU-1 Gene Set

Balsalazide (sodium hydrate)_SNU-423 Gene Set

Carbidopa (monohydrate)_SNU-423 Gene Set

Dapagliflozin ((2S)-1,2-propanediol, hydrate)_SNU-423 Gene Set

Selinexor _SNU-423 Gene Set

Citalopram (hydrobromide)_SNU-423 Gene Set

Pitavastatin (Calcium)_SNU-423 Gene Set

Neratinib (maleate)_SNU-423 Gene Set

Fluvoxamine (maleate)_SNU-423 Gene Set

Omeprazole (sodium)_SNU-423 Gene Set

L-Thyroxine (sodium salt pentahydrate)_SNU-423 Gene Set

Flumatinib (mesylate)_SNU-423 Gene Set

Perindopril (erbumine)_SNU-423 Gene Set

Doxycycline (monohydrate)_SNU-423 Gene Set

Almonertinib (mesylate)_SNU-423 Gene Set